These results are from clinics run by KnowYourStuffNZ and DISC (via needle exchanges). If you have a sample ID starting with 'NEX...', '23_' or '24_' and you've been told your results will be put online, you'll find them below.
If your sample ID is a six digit code (e.g. DX7W2H) find your results here.
There may be some delays with testing samples, so follow-up testing results may take a while to appear. Please check back if you can't find your sample on this page. Thanks for your patience.
September 2024
NEX Chch_2160 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing Methylphenidate and an alkane material consistent with tablet fillers.
Methylphenidate is a prescription stimulant typically prescribed to treat ADHD and narcolepsy. We are not able to determine how much of the drug may be present in this sample.
You can read more about Methylphenidate here [Methylphenidate: Uses, Dosage, Side Effects - Drugs.com], and click here for more information on staying safer when taking prescription stimulants. Please also feel welcome to return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULT:
NEX Chch_2160 - Preliminary
Substance presumed to be: Methylphenidate
Date brought in for testing: First week of September, 2024
Substances detected in the sample: Results inconclusive - waiting for laboratory results.
Our in-clinic testing methods were unable to verify the presence of this substance, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
We recommend waiting until the results of this analysis are back before deciding whether to take this substance. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter), allowing 1 - 1.5 hours for the drug to take effect, and seeing how your body feels before taking more.
Click here for more information on staying safer when taking prescription stimulants.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Tima_28
Substance presumed to be: Methamphetamine
Date brought in for testing: First week of September, 2024
Substances detected in the sample: Methamphetamine - no potent opioid, other drugs, or filler detected.
This sample was consistent with the presence of methamphetamine. On both strip tests and the spectrometer, no fentanyl-type substances, nitazene-type substances, or any other drugs or fillers were detected.
We see a lot of methamphetamine samples which are consistent with the presence of methamphetamine only, but which produce weak or unexpected effects, which can feel similar to a sample which has been substituted or adulterated. We couldn’t detect any filler or adulterant in this sample, and we suspect this effect is most likely to be due to differences in precursors and synthesis methods, which produce different amounts of L-meth versus D-meth (the psychoactive isomer). We’re working to improve our technology to tell this difference.
We wrote an article last year with KnowYourStuffNZ explaining some of these differences – have a read here and feel free to return to the Drug Checking clinic you attended to check on this result for updates.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Tima_29
Substance presumed to be: Methamphetamine
Date brought in for testing: First week of September, 2024
Substances detected in the sample: Methamphetamine - no potent opioid, other drugs, or filler detected.
This sample was consistent with the presence of methamphetamine. On both strip tests and the spectrometer, no fentanyl-type substances, nitazene-type substances, or any other drugs or fillers were detected.
We see a lot of methamphetamine samples which are consistent with the presence of methamphetamine only, but which produce weak or unexpected effects, which can feel similar to a sample which has been substituted or adulterated. We couldn’t detect any filler or adulterant in this sample, and we suspect this effect is most likely to be due to differences in precursors and synthesis methods, which produce different amounts of L-meth versus D-meth (the psychoactive isomer). We’re working to improve our technology to tell this difference.
We wrote an article last year with KnowYourStuffNZ explaining some of these differences – have a read here and feel free to return to the Drug Checking clinic you attended to check on this result for updates.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Tima_30
Substance presumed to be: Methamphetamine
Date brought in for testing: First week of September, 2024
Substances detected in the sample: Methamphetamine - no potent opioid, other drugs, or filler detected.
This sample was consistent with the presence of methamphetamine. On both strip tests and the spectrometer, no fentanyl-type substances, nitazene-type substances, or any other drugs or fillers were detected.
We see a lot of methamphetamine samples which are consistent with the presence of methamphetamine only, but which produce weak or unexpected effects, which can feel similar to a sample which has been substituted or adulterated. We couldn’t detect any filler or adulterant in this sample, and we suspect this effect is most likely to be due to differences in precursors and synthesis methods, which produce different amounts of L-meth versus D-meth (the psychoactive isomer). We’re working to improve our technology to tell this difference.
We wrote an article last year with KnowYourStuffNZ explaining some of these differences – have a read here and feel free to return to the Drug Checking clinic you attended to check on this result for updates.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Tima_31
Substance presumed to be: Amphetamine (speed)
Date brought in for testing: First week of September, 2024
Substances detected in the sample: Amphetamine (speed) – no other drugs or fillers detected.
This sample was consistent with the presence of amphetamine sulfate. On both strip tests and the spectrometer, no fentanyl-type substances, nitazene-type substances, or any other drugs or fillers were detected.
Click here for more information on staying safer when taking amphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2269
Substance presumed to be: MDMA
Date brought in for testing: First week of September, 2024
Substances detected in the sample: MDMA – no other drugs or fillers detected.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2284 - Preliminary
Substance presumed to be: Magic mushroom product
Date brought in for testing: Second week of September, 2024
Substances detected in the sample: Results inconclusive - waiting for laboratory results.
Our in-clinic testing methods were unable to verify the identity of the substances contained, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
We recommend waiting until the results of this analysis are back before deciding whether to take this substance. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter), allowing 1 - 1.5 hours for the drug to take effect, and seeing how your body feels before taking more.
Click here for more information on staying safer when taking magic mushroom products.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_2176 - Preliminary
Substance presumed to be: Clenbuterol
Date brought in for testing: Second week of September, 2024
Substances detected in the sample: Results inconclusive - waiting for laboratory results.
Our in-clinic testing methods were unable to verify the presence of this substance, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
We recommend waiting until the results of this analysis are back before deciding whether to take this substance. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter), allowing 1 - 1.5 hours for the drug to take effect, and seeing how your body feels before taking more.
Click here for more information on staying safer when taking steroids.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_830
Substance presumed to be: Cocaine
Date brought in for testing: Third week of September, 2024
Substances detected in the sample: Cocaine
This sample was consistent with the presence of cocaine hydrochloride, with no other fillers or drugs detected.
Click here for more information on staying safer when taking cocaine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_2212 – PRELIMINARY
Substance presumed to be: Methamphetamine
Date brought in for testing: Second week of September, 2004
Substances detected in the sample: Methamphetamine, possible presence of MDMA
Our in-clinic testing methods detected Methamphetamine in this sample, and suggested that there may also be MDMA present. Our strip tests did not detect any fentanyl, benzodiazepine or nitazene type drugs in this sample.
We have sent this sample to the laboratory for further analysis and we recommend waiting until these results are back before deciding whether to take this substance. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
If more than one drug is present, we are unable to determine how much of each drug was in this sample. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter), allowing 30-60 mins for the drug to take effect, and seeing how you feel before taking more. Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects and overdose.
You can find more information on staying safer when taking Methamphetamine here and for MDMA here.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
NEX Dune_839 – PRELIMINARY
Substance presumed to be: MDMA
Date brought in for testing: Third week of September, 2024
Substances detected in the sample: MDMA, inconclusive filler
This sample was consistent with the presence of MDMA. We were unable to identify the filler material and were also unable to confidently exclude the presence of additional psychoactives. This sample has been sent to the laboratory for further analysis, and this result will be updated as soon as we have more information. We recommend waiting until these results are back before deciding whether to take this substance. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
We are unable to determine how much of a drug is contained with a pressed pill. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter), allowing 60-90 mins for the drug to take effect, and seeing how you feel before deciding whether to take more. Taking an unidentified substance may lead to unpredictable or unexpected effects. Some of the risk may be reduced by finely crushing, mixing, then swallowing only a quarter (or less) of a pill.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
NEX Wgtn_2331 – PRELIMINARY
Substance presumed to be: Progesterone
Date brought in for testing: Third week of September, 2024
Substances detected in the sample: Inconclusive
Our in-clinic testing methods were unable to identify this substance, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the drug checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
We recommend waiting until the results of this analysis are back before deciding whether to take this substance.
If you choose to take progesterone, we recommend making regular appointments to see a trusted medical professional. They can help to monitor your blood pressure and hormone levels. Drug checking can't determine the purity of powdered substances or dosages contained in a vial, but regular medical check-ups and early detection can help you to change your dosing to achieve desired effects and reduce side effects. If you experience any of the following, contact a medical professional: abdominal cramps, back pain, hypotension (low blood pressure) and dizziness. Progesterone can increase risk of blood clots - consult a medical professional before using progesterone if you ever had blood clots in the veins or lungs, painful inflammation of the veins or blockage of a blood vessel in the legs, lungs, brain or heart; or any condition that increases the tendency for you to get blood clots.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
NEX Wgtn_2332
Substance presumed to be: MDMA
Date brought in for testing: Third week of September, 2024
Substances detected in the sample: MDMA, inconclusive filler
This sample was consistent with the presence of MDMA. We were unable to identify the filler material, possibly and oil-like substance.
MDMA can produce unexpected effects for many reasons – including other medications you may be taking, if MDMA or other stimulants have been taken recently, of if your body hasn’t slept or eaten. And, although our equipment didn't identify any additional psychoactive drugs in this sample, there can always be something in the part of the substance we didn’t test.
If this was your sample, you can return to the drug checking clinic you attended for additional advice to keep you and your community safer, or to test further samples.
For more information on staying safer when taking MDMA, click here.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
NEX Wgtn_2336 – PRELIMINARY
Substance presumed to be: Cocaine
Date brought in for testing: Last week of September, 2024
Substances detected in the sample: Cocaine, inconclusive
This sample was consistent with the presence of cocaine, however we were unable to confidently exclude the presence of additional psychoactives – potentially another stimulant class drug. This sample has been sent to the laboratory for further analysis, and this result will be updated as soon as we have more information. We recommend waiting until these results are back before deciding whether to take this substance. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects and overdose (‘overamping’). We cannot provide an accurate assessment of the relative amounts of each substance if this is found to be a mixture. If someone does choose to take this substance, we advise taking a small amount first to see how it affects you. As the substance may not be evenly mixed, the relative proportions of each substance may be different each time, so consider this with your dosing.
Click here for more information on staying safer when taking Cocaine.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
NEX Wgtn_2347
Substance presumed to be: LSD
Date brought in for testing: Last week of September, 2024
Substances detected in the sample: LSD
This sample was found to be consistent with the presence of LSD through reagent testing - no other drugs were detected.
Click here for more information on staying safer when taking LSD.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
NEX Wgtn_2348
Substance presumed to be: MDMA
Date brought in for testing: Last week of September, 2024
Substances detected in the sample: MDMA
This sample was consistent with the presence of MDMA - no other drugs or filler were detected.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
NEX Wgtn_2349
Substance presumed to be: MDA
Date brought in for testing: Third week of September, 2024
Substances detected in the sample: MDMA
This sample was consistent with the presence of MDMA - no other drugs or filler were detected.
MDMA and MDA are structurally very similar drugs with similar effects – they are both stimulants and entactogens, and produce distinctive emotional and pro-social effects. MDA is more potent by weight and subjective intensity relative to MDMA, and has a lower dose range accordingly. It also has a longer duration (6-8 hours vs 3-5 hrs for MDMA) and produces more psychedelic effects and higher activity on dopamine, which may result in higher levels of neurotoxicity than MDMA.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
NEX Wgtn_2350
Substance presumed to be: MDMA
Date brought in for testing: Last week of September, 2024
Substances detected in the sample: MDMA
This sample was consistent with the presence of MDMA - no other drugs or filler were detected.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
August 2024
NEX Wgtn_2145
Substance presumed to be: Methamphetamine
Date brought in for testing: First week of August, 2024
Substances detected in the sample: Methamphetamine
This sample was consistent with the presence of methamphetamine - no other drugs or filler were detected.
For more information on staying safer when taking methamphetamine, click here: Methamphetamine - The Level
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_738
Substance presumed to be: Methamphetamine
Date brought in for testing: Second week of August, 2024
Substances detected in the sample: Methamphetamine - no other drugs or filler material were detected.
Click here for more information on staying safer when taking methamphetamine: Methamphetamine - The Level
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX CHCH_2061 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing Bromazolam.
Bromazolam is a novel benzodiazepine. Novel benzodiazepines, those that have entered the drug market relatively recently, are less well understood than prescription benzos or those that have been on the market for longer, such as alprazolam (Xanax). Dosing information is relatively untested and may be similar or lower than alprazolam, however there are indications that it may stay in your system for twice as long (more than 12 hours), even you no longer feel the effects.
We are unable to determine how much of the drug may be present in this sample. As the substance may not be evenly mixed, the relative proportions of each substance may be different each time. If someone does choose to take this substance, please read the advice in below and in the links provided. Take a smaller dose than may be indicated (e.g. a half or quarter dose), allow 45-60 minutes for the drug to take effect, and see how your body feels before taking more. Make sure you or someone you are with knows the signs to look out for in case of overdose.
INITIAL RESULT:
Substance presumed to be: Alprazolam
Date brought in for testing: Second week of August, 2024
Substances detected in the sample: Possible presence of a benzodiazepine (results inconclusive).
Due to the format of this sample were unable to conduct a full analysis in-clinic, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
Our in-clinic testing indicated a positive strip-test result for a benzodiazepine, with negative strip-test results for nitazene and fentanyl. However, benzo strip-tests react with several benzodiazepines and cannot specify which of these is present. Equally, strip-tests do not detect all types of nitazenes, especially as new nitazenes entered the drug market regularly. We recommend waiting until the result of laboratory analysis are posted before taking this substance.
Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepines, opioids, dissociatives, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. This may look like: slurred speech, severe confusion, delusions, slowed, shallow or stopped breathing, blue fingertips or lips, loss of consciousness. Call 111 immediately to seek medical support.
For more information on staying safer when taking benzodiazepines click here, and for more specific information about novel benzos click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2169
Substance presumed to be: Cocaine
Date brought in for testing: Second week of August, 2024
Substances detected in the sample: Cocaine - no other drugs or filler material were detected.
For more information on staying safer when taking cocaine click here: Cocaine - The Level
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_2070
Substance presumed to be: 1,4-butanediol (1,4-BD)
Date brought in for testing: Third week of August, 2024
Substances detected in the sample: 1,4-butanediol (1,4-BD)
For more information on staying safer when taking 1,4-BD click here
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX CHCH_2084 - UPDATED
UPDATED RESULT
Laboratory analysis has confirmed this sample was consistent with containing Alpha D2PV and eutylone.
If this was your sample, please feel welcome to return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULT
Substance presumed to be: MDMA
Date brought in for testing: Third week of August, 2024
Substances detected in the sample: Alpha D2PV and eutylone
Our in-clinic testing detected the presence of Alpha D2PV and eutylone in this sample. It has been sent to the laboratory for further analysis to confirm these initial results, and we’ll update this result once we have the results of that analysis.
Alpha D2PV and eutylone are both types of synthetic cathinones, a class of stimulant drug. We are unable to determine how much of each substance is in this mixture.
Alpha D2PV is much more potent than MDMA, with a common dose of around 5-15 mg (a common dose of MDMA is 80-120 mg). This cathinone produces a strong, short-lived stimulant effects and at high doses adverse effects can include agitation, paranoia, mania, a racing heart, and hallucinations. Alpha D2PV and related substances have been implicated in harm including deaths internationally, especially when used in combination with other substances and/or when it is misrepresented (e.g. as MDMA or as a less potent cathinone). You can read more about Alpha D2PV here: Alpha-PVP like substance misrepresented as MDMA in Christchurch :: High Alert
Eutylone is also active at a lower doses than MDMA, with a common dose of around 40-80 mg (around half that of MDMA). Eutylone's effects are often described as being similar of MDMA, but with a shorter duration and less euphoric effects. This often leads people to want to take more (redose) which makes it easy to overdose, especially if they are expecting MDMA-like effects.
Side effects from these substances – especially at higher doses – can include insomnia, anxiety, hallucinations, psychosis, paranoia, unusual/fast heartrate, overheating, tremors, convulsions, or seizures. Taking these substances in combination increases the likelihood of experiencing these side effects, and also increases the risk of serotonin syndrome.
If someone plans to take this substance, we recommend waiting until the results of further analysis are available. If you do choose to take this substance, start with a much lower dose than usual, and base this on dosing of Alpha D2PV as the more potent substance. Wait 60-90 minutes for the drug to take effect. Be aware of the high redose potential of these two drugs, and ideally avoid redosing as this is likely to result in the adverse effect described above. Avoid combining with other substances including alcohol. Make sure you or someone with you knows the signs of overdose, and if you experience any of the following symptoms, call 11 immediately and ask for help – you will not get in trouble and it could save a life: feeling extremely agitated or anxious, paranoid or manic, a very fast beating heart, tremors, convulsions, or seizures, suicidal thoughts.
For more information on synthetic cathinones click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2207 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing flualprazolam. No other psychoactive substances were detected.
If this was your sample, please feel welcome to return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULTS
Substance presumed to be: Flualprazolam
Date brought in for testing: Third week of August, 2024
Substances detected in the sample: Possible presence of a benzodiazepine (results inconclusive).
Due to the format of this sample were unable to conduct a full analysis in-clinic, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
Our in-clinic testing indicated a positive strip-test result for a benzodiazepine, with negative strip-test results for nitazene and fentanyl. However, benzo strip-tests react with several benzodiazepines and cannot specify which of these is present. Equally, strip-tests do not detect all types of nitazenes, especially as new nitazenes entered the drug market regularly. We recommend waiting until the result of laboratory analysis are posted before taking this substance.
Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepines, opioids, dissociatives, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. This may look like: slurred speech, severe confusion, delusions, slowed, shallow or stopped breathing, blue fingertips or lips, loss of consciousness. Call 111 immediately to seek medical support.
For more information on staying safer when taking benzodiazepines click here, and for more specific information about novel benzos click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2228 - UPDATED
UPDATED RESULT
Laboratory analysis has confirmed this sample was consistent with progesterone. No other psychoactive substances were detected. Some impurities were detected during laboratory testing, however it is possible that these were breakdown products of progesterone produced during the testing process. We always recommend using a wheel filter for substances administered IV, and you can get advice on these at your local needle exchange.
If this was your sample, please feel welcome to return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULT
Substance presumed to be: Progesterone
Date brought in for testing: Third week of August, 2024
Substances detected in the sample: Results inconclusive
Our in-clinic testing methods were unable to identify this substance, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
We recommend waiting until the results of this analysis are back before deciding whether to take this substance.
If you do choose to take progesterone, we recommend making regular appointments to see a trusted medical professional. They can help to monitor your blood pressure and hormone levels. Drug checking can't determine the purity of powdered substances or dosages contained in a vial, but regular medical check-ups and early detection can help you to change your dosing to achieve desired effects and reduce side effects. If you experience any of the following, contact a medical professional: abdominal cramps, back pain, hypotension (low blood pressure) and dizziness. Progesterone can increase risk of blood clots - consult a medical professional before using progesterone if you ever had blood clots in the veins or lungs, painful inflammation of the veins or blockage of a blood vessel in the legs, lungs, brain or heart; or any condition that increases the tendency for you to get blood clots.
Once a powder is made up into solution, the solution can always become contaminated by bacteria and mould in the air. After a hormone solution has been opened or exposed to air, we strongly recommend using a wheel filter to remove germs. If you're getting illicit / counterfeit hormones, they may already be non-sterile when you get them. Using a wheel filter is always recommended. You can get these, clean needles and syringes, and advice to make your draw-up, preparation and shot safest, from your local needle exchange outlet at https://www.nznep.org.nz/outlets
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2189
Substance presumed to be: MDMA
Date brought in for testing: Third week of August, 2024
Substances detected in the sample: MDMA
For more information on staying safer when taking MDMA, click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_765
Substance presumed to be: Clobromazolam
Date brought in for testing: Fourth week of August, 2024
Substances detected in the sample: Lidocaine, no psychoactive substances detected.
Our in-clinic testing methods were unable to identify a psychoactive substance in this sample, and it was sent to the laboratory for further analysis. Both sets of results identified this sample as consistent with lidocaine, with no psychoactive substances detected.
Just because our equipment didn't identify the drug that may be contained in this sample, does not mean there is no drug contained. There can always be something in the part of your substance we didn’t test. It also doesn’t mean that similar samples won’t contain a psychoactive substance – we recommend coming to get your new substances checked every time. If you choose to take an unidentified substance, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained, or produces unpleasant or harmful effects.
Clobromazolam is thought to be a particularly potent novel benzodiazepine. Little to no dosage information is available for this substance, however it is likely to be active at very low doses (thought to be up to 0.25 mg, possibly lower).
There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. This may look like: slurred speech, severe confusion, delusions, slowed, shallow or stopped breathing, blue fingertips or lips, loss of consciousness. Call 111 immediately to seek medical support.
Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepines, opioids, dissociatives, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
For more information on staying safer when taking benzodiazepines click here and for more specific information about novel benzos click here.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_2133 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing an oil (likely vegetable oil, however the type of oil cannot be determined with our existing analysis methods), and traces of tetrahydrocannabinol (THC).
THC is the main chemical in cannabis that makes you high, while CBD is the main chemical that relieves pain and anxiety.
You can read more about staying safer when taking cannabis here, and please feel welcome to return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULT:
Substance presumed to be: Cannabis (CBD-A)
Date brought in for testing: Last week of August, 2024
Substances detected in the sample: Results inconclusive
Our in-clinic testing methods were unable to identify this substance, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
We recommend waiting until the results of this analysis are back before deciding whether to take this substance. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter), allowing 60-90 minutes for the drug to take effect, and seeing how your body feels before taking more.
For more information on staying safer when taking cannabis, click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_2138 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing traces of Nitrazepam.
Nitrazepam is a long-acting benzodiazepine with intermediate onset commonly used to treat panic disorders, severe anxiety, insomnia, and seizures. It also has sedative properties, as well as amnestic, anticonvulsant, and skeletal muscle relaxant effects. It can stay in someone’s system for 15-38 hours, even if they no longer feel the subjective effects.
We are unable to determine how much of the drug may be present in this sample. As the substance may not be evenly mixed, the relative proportions of each substance may be different each time. If someone does choose to take this substance, please read the advice in below and in the links provided. Take a smaller dose than may be indicated (e.g. a half or quarter dose), allow 45-60 minutes for the drug to take effect, and see how your body feels before taking more. Make sure you or someone you are with knows the signs to look out for in case of overdose.
INITIAL RESULT:
Substance presumed to be: Benzodiazepine (unspecified / inconclusive)
Date brought in for testing: Last week of August, 2024
Substances detected in the sample: Benzodiazepine (unspecified / inconclusive)
Due to the format of this sample were unable to conduct a full analysis in-clinic, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
Our in-clinic testing indicated a positive strip-test result for a benzodiazepine, with negative strip-test results for nitazene and fentanyl. However, benzo strip-tests react with several benzodiazepines and cannot specify which of these is present. Equally, strip-tests do not detect all types of nitazenes, especially as new nitazenes entered the drug market regularly. We recommend waiting until the result of laboratory analysis are posted before taking this substance.
Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepines, opioids, dissociatives, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. This may look like: slurred speech, severe confusion, delusions, slowed, shallow or stopped breathing, blue fingertips or lips, loss of consciousness. Call 111 immediately to seek medical support.
For more information on staying safer when taking benzodiazepines click here, and for more specific information about novel benzos click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_2139 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing traces of Bromazolam.
Bromazolam is a novel benzodiazepine. Novel benzodiazepines, those that have entered the drug market relatively recently, are less well understood than prescription benzos or those that have been on the market for longer, such as alprazolam (Xanax). Dosing information is relatively untested and may be similar or lower than alprazolam, however there are indications that it may stay in your system for twice as long (more than 12 hours), even you no longer feel the effects.
We are unable to determine how much of the drug may be present in this sample. As the substance may not be evenly mixed, the relative proportions of each substance may be different each time. If someone does choose to take this substance, please read the advice in below and in the links provided. Take a smaller dose than may be indicated (e.g. a half or quarter dose), allow 45-60 minutes for the drug to take effect, and see how your body feels before taking more. Make sure you or someone you are with knows the signs to look out for in case of overdose.
INITIAL RESULT:
Substance presumed to be: Bromazolam
Date brought in for testing: Last week of August, 2024
Substances detected in the sample: Benzodiazepine (unspecified / inconclusive)
Due to the format of this sample were unable to conduct a full analysis in-clinic, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
Our in-clinic testing indicated a positive strip-test result for a benzodiazepine, with negative strip-test results for nitazene and fentanyl. However, benzo strip-tests react with several benzodiazepines and cannot specify which of these is present. Equally, strip-tests do not detect all types of nitazenes, especially as new nitazenes entered the drug market regularly. We recommend waiting until the result of laboratory analysis are posted before taking this substance.
Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepines, opioids, dissociatives, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. This may look like: slurred speech, severe confusion, delusions, slowed, shallow or stopped breathing, blue fingertips or lips, loss of consciousness. Call 111 immediately to seek medical support.
For more information on staying safer when taking benzodiazepines click here and for more specific information about novel benzos click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2249
Substance presumed to be: Methylone (bK-MDMA)
Date brought in for testing: Last week of August, 2024
Substances detected in the sample: Cyputylone (n-cyclohexylmethylone), MDMA
We identified the presence of cyputylone, a synthetic cathinone, and MDMA in this sample. We are unable to determine how much of each drug may be present in this sample.
Cyputylone and MDMA are both empathogens (drugs with promote empathy and pro-social behaviour) and stimulant class drugs. While MDMA is well understood, cyputylone is a novel cathinone and limited dosing information is available for this substance. As with most novel cathinones, it is likely that the dose range is much lower than for MDMA or more well characterised cathinones like methylone. Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects, brain toxicity, and overdose.
If someone chooses to take this substance, we recommend researching the substance carefully (including the links below), and taking only a very small amount first to see how it affects you. Wait at least 60-90 minutes before taking any more. As the substance may not be evenly mixed, the relative proportions of cyputylone and MDMA may be different each time, so consider this with your dosing. We recommend not taking it by yourself (have trusted friend(s) who can get help if needed), avoid mixing it with additional drugs, and watching for signs of stimulant overamping: Chest pain or severe heart palpitations, overheating, splitting headache, agitation / delirium, seizure and unconsciousness. If someone experiences concerning symptoms after taking this drug, phone 111 immediately to seek medical support.
For more information on staying safer when taking cathinones, click here and MDMA, click here.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
24_258_124G63
Substance Presumed to be: Ketamine
Date brought in for testing: 4th Week of August
Substances detected in the sample: Ketamine
Ketamine was the only thing that could be detected in this sample. For tips and tricks on reducing your risks with ketamine check out this link.
Email info@knowyourstuff.nz for questions
NEX Dune_752
Substance presumed to be: MDMA
Date brought in for testing: Third week of August, 2024
Substances detected in the sample: 3',4'-Methylenedioxy-N-tert-butylcathinone (tertylone/MDPT)
Both our in-clinic testing and further laboratory analysis confirmed the presence of Tertylone (aka MDPT) in this sample.
Tertylone is classified as a novel stimulant and substituted cathinone, structurally similar compounds include N-ethyl pentylone, pentylone, methylone, and butylone. Novel stimulants, those that have entered the drug market relatively recently, are less well understood than substances that have been on the market for longer. Accurate dosing information and the full range of effects (both short and long term) are unknown.
It is highly likely that Tertylone may produce some similar effects as other stimulants, which peak and wear off much sooner than MDMA. The side effects of these drugs are usually more intense than for MDMA, and can include being awake for multiple days, and intense anxiety and agitation. Cathinones can create a strong urge to re-dose (take more), which can very quickly cause someone to take too much and overdose. If you choose to take this substance, we recommend taking a lower dose (e.g. 1/10th of the amount you might take of MDMA), not using alone, or combining with other substances. If someone experiences concerning symptoms (chest pain, heart palpitations, delirium, seizure, unconsciousness) after taking this drug, call 111 immediately and seek medical support.
Click here for more information on about cathinones.
Contact: DISC Drug Checking team [drugchecking@nznep.org.nz]
July 2024
24_230_8C5XS9
Substance Presumed to be: Methamphetamine
Date brought in for testing: 2nd week of July
Substances detected in the sample: Levamisole
The only substance detected in this sample was levamisole. This is originally an anti-worming drug however this causes some nasty side effects. This does not produce a psychoactive effect.
Ingesting levamisole can seriously reduce your body's ability to fight off even minor infections.
People who snort, smoke, or inject drugs contaminated with levamisole can experience rapidly developing, life-threatening infections. If you develop any wound that will not heal or looks infected consult medical care without delay.
Reminder to use sterile injecting equipment and use a wheel filter to remove germs to reduce the chance of infection. You can get these, clean needles and syringes, and advice to make your draw-up, preparation and shot safest, from our friends over at your local needle exchange outlet here.
If you choose to take a substance that might be this:
• Remember that this substance does not have any psychoactive effects.
• Lower doses are less risky. Start off with a small amount to check how it affects you. In general, swallowing a substance has a slower onset than other methods and means there might be more time to get medical help if needed.
• Avoid using it at the same time as other substances.
• Avoid using it alone. Have a buddy who can help, and call an ambulance, if things go wrong.
• Avoid taking more.
Contact info@knowyourstuff.nz for questions
NEX_Chch_1919
Substance presumed to be: Methamphetamine
Date brought in for testing: First week of July, 2024
Substances detected in the sample: N-isopropylbenzylamine - otherwise known as n-iso. No other psychoactive substances were detected in this sample.
N-iso has been used as a filler or substitute for methamphetamine, but is not known to have psychoactive effects in the sense of a high. People have reported effects from n-iso when smoked as sleepiness/drowsiness, dizziness, digestive issues (feeling gassy/bloated), depressive feelings, anxiety, skin issues such as pimples etc. When injected IV, people have reported intense burning sensations at usual methamphetamine-sized doses, soreness at site of injection, long lasting headaches, queasiness/nausea, bodily discomfort (aches/pains) and sleepiness/drowsiness.
We wrote an article last year with KnowYourStuffNZ explaining more about n-iso, and some of the other things we’ve seen going on with methamphetamine supply – have a read here: What's going on with our methamphetamine? – and feel free to return to the Drug Checking clinic you attended for more harm reduction information and advice.
It’s worth noting that with these substances, misrepresentation can occur anywhere along the supply chain. We advise everyone to come and get their substances checked and not to assume that what you have is what you were told it is.
For further information and harm reduction advice, you can also click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1931 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with cannabis, with tetrahydrocannabinol (THC), detected in chemical analysis. No other psychoactive substances were detected.
THC is the main chemical in cannabis that makes you high, while CBD is the main chemical that relieves pain and anxiety.
Harm reduction advice for cannabis is provided in the initial result below, however please feel welcome to return to the Drug Checking clinic you attended for more information and advice.
INITIAL RESULT
Substance presumed to be: Cannabis (THC-A)
Date brought in for testing: First week of July, 2024
Substances detected in the sample: Cannabis (THC-A)
Our in-clinic testing results did not identify any other psychoactive substances in this sample, but we were unable to conclusively rule out anything else and it has been sent to the laboratory for further analysis. We’ll update this result once we have the results of that analysis.
Cannabis can cause dizziness or nausea; headaches or heart palpitations; incoordination, anxiety or mildly paranoid. If unpleasant effects were experienced as a result of taking this sample, we recommend waiting until the result of further analysis are posted before taking more. However, if someone does choose to take this substance, we recommend starting with a lower dose than usual, allowing 30-45 minutes for the drug to take effect, and seeing how your body feels before taking more. Avoid combining with other substances including alcohol. If you feel unwell, stop taking the substance, focus on your breathing, stay hydrated and sit or lie down.
If you feel very dizzy or uncoordinated, have an irregular heartbeat, have a panic attack, have vomiting, or have disturbing hallucinations, call a doctor or Healthline (0800 611 116). You won't get in trouble if you tell them you've used drugs. They can talk you through the next steps. If you have chest pains, experience severe emotional distress, act violently, experience psychosis or lose consciousness, call 111. These are signs that something more serious is going on.
Click here for more information on staying safer when taking cannabis. If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_693 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing cocaine and levamisole.
Levamisole is a cutting agent which is toxic to humans. High Alert have recently published an article on levamisole which we recommend you read here.
Levamisole can lead to harm including fevers or chills, fatigue, and joint stiffness, inflammation and clotting of small blood vessels in the body, skin lesions and necrosis (tissue death), especially of the ears and nose, problems with bone marrow, such as agranulocytosis, a condition that supresses your immune system and weakens the body’s ability to fight off even lower-level infections. We recommend that you do not consume this substance as we cannot provide an accurate assessment of the relative amounts of cocaine and levamisole in this mixture. Harmful symptoms of levamisole use can appear days after consumption, so it is difficult to assess levels of harm at the time of consumption. Additionally, as these substances may not be evenly mixed, the relative proportions of cocaine and levamisole may be different each time.
If someone does choose to take this substance, take a smaller dose than may be indicated (e.g. a half or quarter dose), allow 30-60 minutes for the drug to take effect, and see how your body feels before taking more. If you start to experience symptoms that may be related to levamisole consumption (especially purple/black skin changes), see your doctor, or call Healthline (0800 611 116). Be honest about your drug use, it will help doctors give you the best treatment.
Please feel welcome to return to the Drug Checking clinic you attended for more information and advice.
INITIAL RESULT
Substance presumed to be: Cocaine
Date brought in for testing: Second week of July, 2024
Substances detected in the sample: Cocaine, potentially an amphetamine-type substance
Our in-clinic testing results did identified that there may be another psychoactive substances in this sample, but we were unable to conclusively identify this and it has been sent to the laboratory for further analysis. We’ll update this result once we have the results of that analysis.
We recommend waiting until the result of further analysis are posted before taking this substance. If you choose to take an unidentified drug, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained, or produces unpleasant or harmful effects. Have someone trusted around who can get help if something goes wrong – you won’t get in trouble with emergency services if you tell them you've used drugs.
Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects and overdose (‘overamping’). We cannot provide an accurate assessment of the relative amounts of each substance if this is found to be a mixture. If someone does choose to take this substance, we advise taking a small amount first to see how it affects you. As the substance may not be evenly mixed, the relative proportions of each substance may be different each time, so consider this with your dosing.
For more information on staying safer when taking cocaine click here, and for information about amphetamines click here and here. If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1962 - UPDATED
UPDATED RESULT:
No drug-type substances were detected in this sample following laboratory analysis. The substance was identified as glycol ester – a modified natural resin. Glycol ethers have many uses; these include use as solvents and as an ingredient in cleaning compounds, liquid soaps, and cosmetics. They are not recommended for consumption and at high levels may cause liver and kidney damage.
While we didn’t detect any psychoactive substances in this sample, it’s always possible that there could be some in the part not submitted for testing. If this was your sample, you are welcome to bring another sample in to be tested, or to return to the Drug Checking clinic you attended for additional advice.
If someone does choose to take this substance, please follow the advice below on taking unidentified substances.
INITIAL RESULT:
Substance presumed to be: Unknown
Date brought in for testing: Second week of July, 2024
Substances detected in the sample: Results inconclusive
Our in-clinic testing results were inconclusive for this sample and it has been sent to the laboratory for further analysis. We’ll update this result once we have the results of that analysis.
Just because our equipment didn't identify the drug that may be contained in this sample, does not mean there is no drug contained. We recommend waiting until the result of further analysis are posted before taking this substance. If you choose to take an unidentified drug, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained, or produces unpleasant or harmful effects. Have someone trusted around who can get help if something goes wrong – you won’t get in trouble with emergency services if you tell them you've used drugs.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1963 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing MDMA with traces of ketamine.
Ketamine is a dissociative drug that acts as both a depressant and has some psychedelic effects. You can read more about ketamine here: Ketamine - The Level.
Ketamine was detected in only trace amounts within this sample and we are unable to determine how much of each drug may be in this sample. It is possible that the presence of ketamine contributed to some unexpected effects from taking this sample.
Mixing stimulants like MDMA and depressants like ketamine means that the two drugs can mask each other’s effects – so there can be a temptation to take more of the substance than planned. If one drug wears off more quickly, you can find yourself suddenly a lot more stimulated, or more sedated. Ketamine is a dissociative anaesthetic that worsens your coordination, which you may be less aware of while under the influence of MDMA, increasing risk of physical injury. Large doses of ketamine and MDMA together may create risk of serotonin syndrome, which can be fatal - especially if somebody is taking MAOI type anti-depressants.
If someone plans to take this substance, start with a lower dose than usual and allow 45-90 minutes for the drug to take effect. Ideally avoid redosing, and if you do be aware of the different onset times of these two drugs. Depending on the route of administration, it is likely that ketamine will come on and wear off more quickly than MDMA. You can read more about this here: Ketamine and MDMA. Avoid combining with other substances including alcohol.
If this was your sample, please fell welcome to return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULTS
Substance presumed to be: MDMA
Date brought in for testing: Second week of July, 2024
Substances detected in the sample: MDMA
Our in-clinic testing results did not identify any other psychoactive substances in this sample, but we were unable to conclusively rule out anything else and it has been sent to the laboratory for further analysis. We’ll update this result once we have the results of that analysis.
MDMA is a stimulant and entactogen, and produces distinctive emotional and pro-social effects.
If unpleasant effects were experienced as a result of taking this sample, we recommend waiting until the result of further analysis are posted before taking more. However, if someone does choose to take this substance, we recommend starting with a lower dose than usual, allowing 45-90 minutes for the drug to take effect, and seeing how your body feels before taking more. Avoid combining with other substances including alcohol.
Click here for more information on staying safer when taking MDMA. If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1964 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing MDMA with traces of ketamine and polyethylene (polythene).
Ketamine is a dissociative drug that acts as both a depressant and has some psychedelic effects. You can read more about ketamine here: Ketamine - The Level. Polythene is the most commonly produced plastic, commonly used for packaging material.
Ketamine was detected in only trace amounts within this sample and we are unable to determine how much of each drug may be in this sample. It is possible that the presence of ketamine contributed to some unexpected effects from taking this sample.
Mixing stimulants like MDMA and depressants like ketamine means that the two drugs can mask each other’s effects – so there can be a temptation to take more of the substance than planned. If one drug wears off more quickly, you can find yourself suddenly a lot more stimulated, or more sedated. Ketamine is a dissociative anaesthetic that worsens your coordination, which you may be less aware of while under the influence of MDMA, increasing risk of physical injury. Large doses of ketamine and MDMA together may create risk of serotonin syndrome, which can be fatal - especially if somebody is taking MAOI type anti-depressants.
If someone plans to take this substance, start with a lower dose than usual and allow 45-90 minutes for the drug to take effect. Ideally avoid redosing, and if you do be aware of the different onset times of these two drugs. Depending on the route of administration, it is likely that ketamine will come on and wear off more quickly than MDMA. You can read more about this here: Ketamine and MDMA. Avoid combining with other substances including alcohol.
If this was your sample, please feel welcome to return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULTS
Substance presumed to be: MDMA
Date brought in for testing: Second week of July, 2024
Substances detected in the sample: MDMA
Our in-clinic testing results did not identify any other psychoactive substances in this sample, but we were unable to conclusively rule out anything else and it has been sent to the laboratory for further analysis. We’ll update this result once we have the results of that analysis.
MDMA is a stimulant and entactogen, and produces distinctive emotional and pro-social effects.
If unpleasant effects were experienced as a result of taking this sample, we recommend waiting until the result of further analysis are posted before taking more. However, if someone does choose to take this substance, we recommend starting with a lower dose than usual, allowing 45-90 minutes for the drug to take effect, and seeing how your body feels before taking more. Avoid combining with other substances including alcohol.
Click here for more information on staying safer when taking MDMA. If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2055 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing venlafaxine.
Venlafaxine is from of a group of antidepressants called serotonin and noradrenaline reuptake inhibitors, or SNRIs.
For more information about venlafaxine and how to stay safer using this substance, click here: Venlafaxine - Drugs.com and here: Medsafe - Enlafax. There are interactions between SNRIs and many other substances including MDMA and other amphetamines. SNRIs limit the subjective effects of these substances, which can lead people to take more of their substance to feel the desired effects. This can lead to risk of serotonin syndrome, which can be fatal.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULT
Substance presumed to be: Unknown
Date brought in for testing: Second week of July, 2024
Substances detected in the sample: Results inconclusive
Our in-clinic testing results were inconclusive for this sample and it has been sent to the laboratory for further analysis. We’ll update this result once we have the results of that analysis.
Just because our equipment didn't identify the drug that may be contained in this sample, does not mean there is no drug contained. We recommend waiting until the result of further analysis are posted before taking this substance. If you choose to take an unidentified drug, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained, or produces unpleasant or harmful effects. Have someone trusted around who can get help if something goes wrong – you won’t get in trouble with emergency services if you tell them you've used drugs.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_704
Substance presumed to be: Ketamine
Date brought in for testing: Third week of July, 2024
Substances detected in the sample: ketamine
This sample was consistent with the presence of ketamine - no other drugs or filler were detected.
This sample was analysed both via FT-IR and using reagents. Both FT-IR and reagent results indicate that this sample contains ketamine only. For more information on staying safer when taking ketamine, click here.
Effects of taking a substance can sometimes vary depending on set (mindset – how we are feeling) and setting (our surrounding environment). This can be especially the case with substances that have psychedelic or dissociative effects.
If unpleasant effects were experienced as a result of taking this sample, we recommend starting with a lower dose than usual, allowing 30-45 minutes for the drug to take effect, and seeing how your body feels before taking more. Avoid combining with other substances including alcohol.
We recommend that this substance is crushed and mixed thoroughly prior to consumption. Crushing and mixing the substance will lower the risk of consuming a high concentration of contaminant, should anything be present that was not detected in the sample submitted for testing.
Please feel welcome to return to your local drug checking clinic with your sample if there is continuation of uncharacteristic effects following consumption.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_714
Substance presumed to be: Ketamine
Date brought in for testing: Fourth week of July, 2024
Substances detected in the sample: MDMA
This sample was consistent with the presence of MDMA - no other drugs or filler were detected.
You can read more about MDMA and how to stay safer if you choose to take this substance here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_719
Substance presumed to be: MDMA
Date brought in for testing: Fourth week of July, 2024
Substances detected in the sample: MDMA, sucrose.
This sample was consistent with the presence of MDMA and sucrose (sugar).
We cannot provide an accurate assessment of the relative amounts of each substance in this mixture. We recommend treating this substance as though it is MDMA when dosing. Starting with your usual dose (or check out the link below for a guide to dosing MDMA), allowing 45-90 minutes for the drug to take effect, and seeing how your body feels before taking more.
As the substance may not be evenly mixed, the relative proportions of MDMA and sucrose may be different each time, so consider this with your dosing. We recommend that this substance is crushed and mixed thoroughly prior to consumption, as this likely to give a more consistent mixture.
For more information on staying safer when taking MDMA, click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_2008 - UPDATE
UPDATED RESULT:
Laboratory analysis found that this sample contains bromazolam with traces of methamphetamine.
Bromazolam is a novel benzodiazepine. In addition to the information below, you can find more about staying safer when taking bromazolam and other novel benzos here: Bromazolam and other novel benzos - The Level.
Methamphetamine is a stimulant class drug. We detected very small amounts in the sample submitted for testing, and we are unable to say how much might be in the rest of this bag. For more information on staying safer when taking methamphetamine, click here: Methamphetamine - The Level
If someone does choose to take this substance, please read the advice in below and in the links provided. Take a smaller dose than may be indicated (e.g. a half or quarter dose), allow 30-60 minutes for the drug to take effect, and see how your body feels before taking more. Make sure you or someone you are with knows the signs to look out for in case of overdose.
If this was your sample, please feel welcome to return to the Drug Checking clinic you attended for more information and advice.
INITIAL RESULT:
Substance presumed to be: Flualprazolam
Date brought in for testing: Fourth week of July, 2024
Substances detected in the sample: Possible presence of a benzodiazepine (results inconclusive).
Due to the format of this sample were unable to conduct a full analysis in-clinic, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
Our in-clinic testing indicated a positive strip-test result for a benzodiazepine, with negative strip-test results for nitazene and fentanyl. However, benzo strip-tests cannot specify which of the benzodiazepine that they react with is present. Equally, strip-tests do not detect all types of nitazenes, especially as new nitazenes entered the drug market regularly. We recommend waiting until the result of laboratory analysis are posted before taking this substance.
Novel benzodiazepine, those that have entered the drug market relatively recently, are less well understood than prescription benzos or those that have been on the market for longer. Flualprazolam is structurally similar to alprazolam (Xanax), however accurate dosing information is not yet available and there are indications that it may stay in your system for twice as long (more than 12 hours), even you no longer feel the effects.
Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepines, opioids, dissociatives, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. This may look like: slurred speech, severe confusion, delusions, slowed, shallow or stopped breathing, blue fingertips or lips, loss of consciousness. Call 111 immediately to seek medical support.
For more information on staying safer when taking benzodiazepines click here, and for more specific information about novel benzos click here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX CHCH_2018 - UPDATED
UPDATED RESULT
Laboratory analysis has confirmed this sample was consistent with containing Dimethyl sulfoxide (DMSO), desalkylquazepam and desalkylflurazepam.
DMSO is a chemical that dissolves many organic and inorganic substances and was the main component in this sample. While DMSO is used in topical prescription medicines to help them get through the skin, it can affect proteins, carbohydrates, fats, and water in the body. Our analyses indicate that the concentration of DMSO in this sample is very high. This concentration of DMSO is very likely to be toxic and to cause damage to cell membranes it comes into contact with. Contact with the skin may cause stinging and burning, and/or blistering in delicate areas such as the mouth or nose. Some non-prescription DMSO products are industrial grade. These aren't intended for human use and can contain impurities that can cause health issues. As DMSO is easily absorbed through the skin, it can carry these impurities into the body. DMSO can also cause damage to the liver and kidneys. Injecting DMSO by IV might cause red blood cells to break down, as red blood cell membranes cannot repair themselves. Avoid inhaling the vapor, as in concentrated amounts this may cause headache, dizziness, and sedation.
Desalkylquazepam and desalkylflurazepam are a novel, long-lasting benzodiazepines. Desalkylflurazepam is a break down of desalkylquazepam, and it’s possible that this may have been produced in the analysis process – however we can’t know this for sure and it may be part of the original sample. Little to no dosage information is available for these substances, however they are likely to be active at very low doses (less than 1 mg, possibly much lower).
If someone chooses to take this substance, we strongly recommend first diluting it 1 part sample to 9 parts of propylene glycol (PG, ideally use this) or water (if PG is not accessible) to reduce the harmful effects of DMSO. If using PG, the sample can be mixed all at once as a batch if preferred. If using water, we recommend doing this for each dose, as benzos can drop out of water more easily (possibly even if they’re dissolved in DMSO), and this may affect your dosing the next time round if done as a batch. Whichever dilutant is used (PG or water), make sure the solution is well mixed each time, and remember that even with doing this the amount of active substance may vary between each dose. Each time: Try a drop or two of the diluted substance on your tongue first, and wait to see if you notice any unusual sensations before taking any more – we recommend taking orally above other common routes of administration. Take a smaller dose than may be indicated (e.g. a half or quarter dose), allow 30-60 minutes for the drug to take effect, and see how your body feels before taking more. Please read the advice given below in addition to this advice and make sure you or someone you are with knows the signs to look out for in case of overdose.
If this was your sample, please feel welcome to return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
INITIAL RESULT
Substance presumed to be: Diazepam (Valium)
Date brought in for testing: Last week of July, 2024
Substances detected in the sample: Possible presence of a benzodiazepine (results inconclusive).
Due to the format of this sample were unable to conduct a full analysis in-clinic, and this sample is currently at the laboratory for further analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
Our in-clinic testing indicated a positive strip-test result for a benzodiazepine, with negative strip-test results for nitazene and fentanyl. However, benzo strip-tests cannot specify which of the benzodiazepine that they react with is present. Equally, strip-tests do not detect all types of nitazenes, especially as new nitazenes entered the drug market regularly. We recommend waiting until the result of laboratory analysis are posted before taking this substance.
If someone does choose to take this substance, take a smaller dose than may be indicated (e.g. a half or quarter dose), allow 30-60 minutes for the drug to take effect, and see how your body feels before taking more. Only carry what you intend to use as benzos can have a high redose compulsion.
Take breaks from using benzos as tolerance and dependency can build fast. Do not stop using suddenly if you are dependent, it can cause seizures- dangerous potentially life threatening seizures.
Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepines, opioids, dissociatives, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. This may look like: slurred speech, severe confusion, delusions, slowed, shallow or stopped breathing, blue fingertips or lips, loss of consciousness. Call 111 immediately to seek medical support.
For more information on staying safer when taking benzodiazepines click here: Benzodiazepines - The Level and for more specific information about novel benzos click here: Bromazolam and other novel benzos - The Level
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
June 2024
NEX Nels_07 - UPDATED
UPDATED RESULT:
Laboratory analysis detected methamphetamine and N,N-Dimethylamphetamine in this sample.
N,N-Dimethylamphetamine (DMA) is an amphetamine analogue of methamphetamine. It is sometimes found as an impurity in preparations of methamphetamine. DMA is noted to have weaker stimulant effects than amphetamine or methamphetamine.
DMA is less neurotoxic than methamphetamine, however the same advice around taking stimulants applies to this substance, especially when found in combination with methamphetamine. We cannot provide an accurate assessment of the relative amounts of each substance in this mixture. If someone does choose to take this substance, we advise taking a small amount first to see how it affects you. As the substance may not be evenly mixed, the relative proportions of DMA and methamphetamine may be different each time, so consider this with your dosing.
Please feel welcome to return to the Drug Checking clinic you attended for more harm reduction advice.
INITIAL RESULT
Substance presumed to be: Methamphetamine
Date brought in for testing: First week of June, 2024
Substances detected in the sample: Methamphetamine
This sample was consistent with the presence of methamphetamine - no other drugs or filler were detected.
Please note: The final result for this sample is still being reviewed by the laboratory, and is subject to change.
We see a lot of methamphetamine samples which are consistent with the presence of methamphetamine only, but which produce weak or unexpected effects, which can feel similar to a sample which has been substituted or adulterated. We couldn’t detect any filler or adulterant in this sample, and we suspect this effect is most likely to be due to differences in precursors and synthesis methods, which produce different amounts of L-meth versus D-meth (the psychoactive isomer). We’re working to improve our technology to tell this difference, and will update this result once the laboratory has been able to determine the chemical handedness of this sample.
We wrote an article last year with KnowYourStuffNZ explaining some of these differences – have a read here and feel free to return to the Drug Checking clinic you attended to check on this result for updates.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Nels_08
Substance presumed to be: Estradiol enanthate
Date brought in for testing: First week of June, 2024
Substances detected in the sample: Estradiol enanthate
This sample was consistent with the presence of estradiol enanthate.
Estradiol enanthate is a prescription estrogen hormone. It is a preferred hormone treatment as it most closely resembles estrogen naturally produced in humans.
If you choose to take this substance, we recommend making regular appointments to see a trusted medical professional. They can help to monitor your blood pressure and hormone levels. Drug checking can't determine the purity of powdered substances or dosages contained in a vial, but regular medical check-ups and early detection can help you to change your dosing to achieve desired effects and reduce side effects.
Estradiol can increase risk of blood clots, or cause damage to your liver. Consult a medical professional before using estradiol if you ever had blood clots in the veins or lungs, painful inflammation of the veins or blockage of a blood vessel in the legs, lungs, brain or heart; any condition that increases the tendency for you to get blood clots; severe liver problems or porphyria. See a doctor immediately If you notice any of the following: yellowing of your skin or the whites of your eyes (jaundice) - these may be signs of a liver disease; rise in blood pressure (symptoms may be headache, tiredness, dizziness); migraine-like headaches which happen for the first time.
Besides the specific drug contained, once hormones are made up into solution, the solution can always become contaminated by bacteria and mould in the air. After a hormone solution has been opened or exposed to air, we strongly recommend using a wheel filter to remove germs. If you're getting illicit / counterfeit hormones, they may already be non-sterile when you get them. Using a wheel filter is always recommended. You can get these, clean needles and syringes, and advice to make your draw-up, preparation and shot safest, from your local needle exchange outlet at https://www.nznep.org.nz/outlets
More information on staying safer when taking estradiol can be found here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698243/
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1800
Substance presumed to be: MDMA
Date brought in for testing: First week of June, 2024
Substances detected in the sample: MDMA, creatine
Laboratory analysis has confirmed this sample was consistent with containing MDMA, no other psychoactive drugs were detected. Creatine is a dietary supplement that is not psychoactive and is commonly seen as a filler to psychoactive substances including MDMA.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1841- UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing ketamine - no other psychoactive drugs or fillers were detected.
Click here for more information on staying safer when taking ketamine. Please also feel welcome to return to the Drug Checking clinic you attended for more information and advice.
INITIAL RESULT:
Substance presumed to be: Ketamine
Date brought in for testing: Third week of June, 2024
Substances detected in the sample: Ketamine
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
This substance was consistent with the presence of ketamine using our tools in-clinic however has been sent for further laboratory testing. Effects of taking a substance can sometimes vary depending on set (mindset – how we are feeling) and setting (our surrounding environment). This can be especially the case with substances that have psychedelic or dissociative effects. Click here for more information on staying safer when taking ketamine.
A notification has recently been issued about a ketamine analogue circulating in the Wellington region which have been sold misrepresented as ketamine. We have not detected an analogue in this sample however our laboratory testing is able to detect these analogues should they be represent in the sample submitted for analysis. You can read this notification here and sign up for future alerts and notifications here.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_1923
Substance presumed to be: Unknown
Date brought in for testing: Third week of June, 2024
Substances detected in the sample: Kaolin – no psychoactives detected.
Kaolin is a type of clay found in nature. It is sometimes used to make medicine used to stop bleeding and for a condition that involves swelling and sores in the mouth (oral mucositis), and is also used as the basis for cosmetic and skincare products.
Kaolin is also used as a filler in tablets; we did not detect any psychoactives in this sample.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_1962
Substance presumed to be: GHB
Date brought in for testing: Fourth week of June, 2024
Substances detected in the sample: 1,4-BD
GHB and 1,4-BD are similar-feeling drugs with different dosages. Like GBL, 1,4-BD is turned into GHB in your body after you take it. Because of this, 1,4-BD may take longer to kick in and may last for longer. This means it may be easier to overdose on than GHB.
Click here for more information on staying safer when taking 1,4-BD - including important information on the differences in effects, onset times and dosing between GHB, GBL and 1,4-BD.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
24_208_4
Substance presumed to be: Ketamine
Date brought in for testing: First week of June
Substances detected in the sample: 2-Fluoro-2-oxo PCE
2-Fluoro-2-Oxo-PCE (aka CanKet, 2F-NENDCK) is a ketamine analogue synthesised to be similar to the dissociative anaesthetic ketamine. Although structurally similar, ketamine analogues, such as 2-Fluoro-2-Oxo-PCE, can produce unexpected and unpredictable effects. In this case there is a delay of onset, a higher risk of and longer K-hole, Nausea, Visual disturbance and an overall longer duration.
If you do choose to take 2-Fluoro-2-Oxo-PCE, don’t use it alone, and don’t mix with other substances (especially depressant drugs like alcohol, opioids and the GHB/GBL family) and make sure you are in a safe environment.
A High Alert notification was recently published about this substance – please read this notification for more important information and ways to stay safer.
Contact info@knowyourstuff.nz for questions
NEX Dune_663 - UPDATED
UPDATED RESULT:
Laboratory analysis identified methadone in this sample. The analysis noted that the sample liquid was aqueous (water-like) and had acidic properties.
We are unable to determine the amount of methadone contained in the sample. Just because we did not detect methadone during in-clinic analysis, this does not indicate that the amount of methadone is more or less than presumed. It may be that the sample was not evenly mixed and another sample from the same bottle might contain more or less methadone than the sample submitted for checking. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter dose), allowing 30-60 minutes for the drug to take effect, and seeing how your body feels before taking more.
If this was your sample, please feel welcome to return to the Drug Checking clinic you attended for more information based on this result.
INITIAL RESULT:
Substance presumed to be: Methadone
Date brought in for testing: Fourth week of June, 2024
Substances detected in the sample: Results inconclusive
Our in-clinic testing results were inconclusive for this sample and it has been sent to the laboratory for further analysis. We’ll update this result once we have the results of that analysis.
Just because our equipment didn't identify the drug that may be contained in this sample, does not mean there is no drug contained. If you choose to take an unidentified drug, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained, or produces unpleasant or harmful effects. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter dose), allowing 30-60 minutes for the drug to take effect, and seeing how your body feels before taking more.
Always have naloxone available when using opioids if possible, as this can be use to reverse an opioid overdose. If you can have a sober buddy with you and make sure they know the signs of an opioid overdose. Opioid overdoses can happen quickly and can be deadly if someone doesn’t get medical help. If someone is overdosing you should call 111 or get medical help immediately, and administer naloxone if available. The signs of an opioid overdose include: unconsciousness/non-responsiveness, difficulty breathing, making choking, gurgling or snoring sounds, blue lips, tongue and hands and their skin is cool and pale, and/or pinpoint pupils.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Click here for more information on staying safer when taking opioids: Heroin and Prescription Opioids
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1864 – UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing ketamine and tadalafil (Cialis).
Laboratory analysis did not detect bromazolam in this sample, however it’s always possible that small amounts of a substance can be present in the original batch/bag, but don’t make it into the sample that gets tested. In this case, it’s possible that the sample tested in clinic did contain a small amount of bromazolam, and the sample sent away for further analysis did not.
If bromazolam is present within this sample, this is high risk in combination with ketamine. Overdose is much more likely if benzodiazepines are combined with other depressants, including dissociatives such as ketamine, other benzodiazepines, opioids, fantasy-type (G/1,4-BD) drugs or alcohol – or at high or repeated doses. Such combinations greatly increase risks of vomiting, stopping breathing, or death. There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose.
Combining tadalafil and ketamine may lead to increased side effects. Both ketamine and tadalafil increase likelihood of nausea/vomiting, confusion, dizziness/fainting, difficulty with moving, reduced sensitivity to touch, changes to heartrate, and urinary tract infections (UTI).
We recommend that if someone intends taking this combination of substances, take a smaller dose than may be indicated (e.g. a half or quarter dose), allow 30-45 minutes for the drug to take effect, and see how your body feels before taking more. Ideally be in a safe, familiar environment and be aware that moving around on of this combination may be ill advised due to risk of physical injury. Stay hydrated and empty your bladder before sleeping to reduce the impact on your renal system. If you or anybody experiences slow/shallow/no breathing, or blue fingertips or lips after taking this substance, make sure someone phones 111 immediately to seek medical support.
Click these links for more information on staying safer when taking tadalafil and ketamine. Information on bromazolam is provided in the original result below.
Please feel welcome to return to the Drug Checking clinic you attended for more information and advice.
INITIAL RESULTS
Substance presumed to be: Tadalafil (Cialis)
Date brought in for testing: Third week of June, 2024
Substances detected in the sample: Tadalafil (Cialis) and bromazolam
Our in-clinic testing results indicated that bromazolam was also contained in this sample, based on our FTIR analysis and benzo test strips. It has been sent to the laboratory for further analysis to confirm these initial results, and we’ll update this result once we have the results of that analysis.
Tadalafil is a pharmaceutical drug that relaxes muscles of the blood vessels and increases blood flow to particular areas of the body, and is typically prescribed as a sexual aid. You can click here for more information on staying safer when taking tadalafil.
Bromazolam is a novel benzodiazepine – one that has entered the drug market relatively recently, and so it is less well understood than prescription benzos or those that have been on the market for longer. Bromazolam is active at lower doses than many other benzos, and can stay in your system for more than 12 hours, even you no longer feel the effects. Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepine, opioid, dissociative, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
We are unable to determine the amount of each drug contained in the sample. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter dose), allowing 30-45 minutes for the drug to take effect, and seeing how your body feels before taking more. There is no overdose reversal agent available for first-aid in case of benzodiazepine overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. If you or anybody experiences slow / shallow / no breathing, or blue fingertips or lips after taking this substance, make sure someone phones 111 immediately to seek medical support.
For more information on staying safer when taking benzodiazepines click here, and for specific information about bromazolam click here.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_1962
Substance presumed to be: Gamma-hydroxybutyric acid (GHB)
Date brought in for testing: Third week of June, 2024
Substances detected in the sample: 1,4-butanediol (1,4-BD)
GHB and 1,4-BD are similar-feeling drugs, but it’s important to be aware that while these substances are similar, their dosages, onset times and subjective effects can be different. 1,4-BD is a GHB pro-drug – it is converted to GHB in the body. Because of that it can have a longer onset time and may not give the same type of high as GHB. This can sometimes lead people to take more before the full effects are felt, which can lead to overdosing.
If someone chooses to take this substance, we recommend starting with a small dose, allowing 30-45 minutes for the drug to take effect, and seeing how your body feels. Wait at least 60-90 minutes before taking more. Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other fantasy-type (G/1,4-BD) drugs, benzodiazepine, opioids, dissociatives or alcohol greatly increases risks of vomiting, stopping breathing, or death.
Click here for more information on staying safer when taking GHB-type drugs including GBL and 1,4-BD.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_1985
Substance presumed to be: Pregabalin
Date brought in for testing: Third week of June, 2024
Substances detected in the sample: No psychoactive substances detected.
Our in-clinic testing results were inconclusive for this sample and it was sent to the laboratory for further analysis. Neither our in-clinic methods or laboratory analysis detected an psychoactive substances in this sample.
Just because our equipment didn't identify the drug that may be contained in this sample, does not mean there is no drug contained. If someone chooses to take an unidentified drug, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained, or produces unpleasant or harmful effects. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter dose), allowing 30-60 minutes for the drug to take effect, and seeing how your body feels before taking more. Have someone trusted around who can get help if something goes wrong – you won’t get in trouble with emergency services if you tell them you've used drugs.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Click here for more information on staying safer when taking pregabalin.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_1986
Substance presumed to be: Pregabalin
Date brought in for testing: Third week of June, 2024
Substances detected in the sample: No psychoactive substances detected.
Our in-clinic testing results were inconclusive for this sample and it was sent to the laboratory for further analysis. Neither our in-clinic methods or laboratory analysis detected an psychoactive substances in this sample.
Just because our equipment didn't identify the drug that may be contained in this sample, does not mean there is no drug contained. If someone chooses to take an unidentified drug, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained, or produces unpleasant or harmful effects. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter dose), allowing 30-60 minutes for the drug to take effect, and seeing how your body feels before taking more. Have someone trusted around who can get help if something goes wrong – you won’t get in trouble with emergency services if you tell them you've used drugs.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
Click here for more information on staying safer when taking pregabalin.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_2007 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing ketamine with traces of cocaine.
Harm reduction advice for these substances is provided in the initial result below, however please feel welcome to return to the Drug Checking clinic you attended for more information and advice.
INITIAL RESULT
Substance presumed to be: Ketamine - preliminary
Date brought in for testing: Fourth week of June, 2024
Substances detected in the sample: Ketamine, possibly cocaine.
Our in-clinic testing results indicated that cocaine might be present in this sample, but we were unable to determine this conclusively and it has been sent to the laboratory for further analysis. We’ll update this result once we have the results of that analysis.
Combining depressants (like ketamine) and stimulants (like cocaine) can lead to unexpected effects, and may mask the effects of each drug, which can suddenly be apparent if one wears off more quickly than the other. If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated, allowing 30-45 minutes for the drug to take effect, and seeing how your body feels before taking more. We are unable to determine the amount of each drug contained in the sample, so if this is a mixture, the substances may not be evenly mixed, the relative proportions of ketamine and cocaine may be different each time, so consider this with your dosing. Ketamine is a dissociative anaesthetic that worsens your coordination, which you may be less aware of while under the influence of cocaine - moving around on of this combination may be ill advised due to risk of physical injury.
If this was your sample, you can return to the Drug Checking clinic you attended for additional advice to keep you and your community safer.
For more information on staying safer when taking these substances, click here: ketamine and cocaine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
24_12_6TVKXY
Substance Presumed to be: Masteron Enanthate
Date brought in for testing: 2nd week of June
Substances detected in the sample: Drostanolone Enanthate (ester of drostanolone) + Benzyl benzoate +Benzylalcohol
There are two versions of Masteron the Propionate and the Ethanoate. This tested consistent with the ethanoate ester. Note that the half-life for this ester is longer. Side effects to watch out for are increased androgenic activity, testosterone suppression and cholesterol issues. Monitor these by getting regular blood tests with a trusted GP.
Steroid solutions can always become contaminated by bacteria and mould in the air. After a steroid solution has been opened or exposed to air, we strongly recommend using a wheel filter to remove germs. If you're getting illicit / counterfeit steroids, they may already be non-sterile when you get them. Using a wheel filter is always recommended when you're not sure how a vial has been prepared. You can get these, clean needles and syringes, and advice to make your draw-up, preparation and shot safest, from our friends over at your local needle exchange outlet here.
contact info@knowyourstuff.nz for questions
24_12_WXDG87
Substance Presumed to be: Nandrolone Phenylpropionate
Date brought in for testing: 2nd Week of June
Substances detected in the sample: Nandrolone phenylpropionate
(ester of nandrolone) + Benzyl benzoate + Benzylalcohol
Steroids can increase your blood pressure, cholesterol (which can lead to heart disease or failure), or cause damage to your kidneys, liver, nerves and connective tissue. In all cases, a trusted medical professional can help to monitor your blood pressure and hormone levels. Drug Checking can't determine the dosage contained in a vial, but regular check-ups and early detection can help you to change your dosing/steroid to reduce side effects, and make sure you get the results you want while reducing your risks
Steroid solutions can always become contaminated by bacteria and mould in the air. After a steroid solution has been opened or exposed to air, we strongly recommend using a wheel filter to remove germs. If you're getting illicit / counterfeit steroids, they may already be non-sterile when you get them. Using a wheel filter is always recommended when you're not sure how a vial has been prepared. You can get these, clean needles and syringes, and advice to make your draw-up, preparation and shot safest, from our friends over at your local needle exchange outlet here.
contact info@knowyourstuff.nz for questions
24_13_011CBA-UPDATED
Substance Presumed to be: Cocaine
Date brought in for testing: 3rd week of June
Substances detected in the sample: No psychoactive detected- Update: an amino acid-type compound
Update 26/07/2024 Further analysis showed this to be an amino acid-type compound. Testing was unable to determine which one.
No psychoactive was detected in this sample. We suggest not consuming this substance. Standard harm reduction principles apply.
Contact info@knowyourstuff.nz for questions
Sample ID: 24_13_033KJL - UPDATED
Substance Presumed to be: Methamphetamine
Date brought in for testing: 3rd Week of June
Substances detected in the sample: No psychoactive detected- update: Aluminium sulphate
Update 26/07/2024 Further analysis showed this to be aluminium sulphate. While this is generally considered non-toxic in low amounts it does cause irritation and local tissue damage when ingested, smoked or injected. We recommend not consuming this substance
No psychoactive was detected in this sample. We suggest not consuming this substance. Standard harm reduction principles apply.
Contact info@knowyourstuff.nz for questions
24_13_511WPA
Substance Presumed to be: Oxycodone
Date brought in for testing: 3rd week of June
Substances detected in the sample: Phenanthroline+ Diethylene glycol
No opiate was detected in this sample, both chemicals are toxic. A high-alert notification has been released. For more information see the notification here
contact info@knowyourstuff.nz for questions
24_13_636CKM
Substance Presumed to be: Ketamine
Date brought in for testing: 3rd Week of June
Substances detected in the sample: Ketamine + MSM (filler)
Ketamine was detected in the sample along with the filler MSM. MSM tends to be a little gunky in your nose so get your hands on a saline spray. For more information on reducing risks with ketamine check out this link
contact info@knowyourstuff.nz for questions
24_13_076SBC
Substance Presumed to be: MDMA
Date brought in for testing: 3rd week of June
Substances detected in the sample: MDMA
No other psychoactives could be detected in this sample. For tips to stay safe whilst using MDMA follow this link
contact info@knowyourstuff.nz for questions
24_221_76P8RE
Substance Presumed to be: MDMA
Date brought in for testing: last week of June
Substances detected in the sample: MDMA + Dimethylsulphone (MSM)*
The only two substances that could be detected in this sample were MDMA and MSM. When fillers are found in samples it's a good idea to consume orally and treat it as if it didn't have filler. you can always take more but you can't take less! Find out more about how to reduce your risks with MDMA here.
*Testing limitations meant that we could not confirm or deny the presence of peanuts in this sample.
Contact info@knowyourstuff.nz for questions
May 2024
24_8_2483DG
Substance Presumed to be: Bromazolam
Date brought in for testing: First week of May
Substances detected in the sample: (Preliminary result) N-Desethyletonitazene
Please note: The final result for this sample is still being reviewed by the laboratory, and is subject to change. If this was your sample, you can return to the Drug Checking clinic you attended, for additional advice to keep you and your community safer.
We did not detect diazepam in this sample. The only substance identified was desethyletonitazene, a very potent novel opioid drug. Desethyletonitazene may be up to 10 times as potent as fentanyl.
Fentanyl test strips will not detect the presence of a nitazene. You can now pre-order Nitazene testing strips from The Level. Different nitazenes can have dramatically different potencies, including when injected versus taken orally (can be exponentially more potent when taken intravenously). Nitazenes are associated with high degrees of harm in NZ, including hospitalisation and death. Both opioid-naïve and opioid-experienced clients are highly at risk of overdose or death from nitazenes. Volumetric dosing can be particularly challenging with nitazenes due to differences in solubility compared with other opioids, and is not necessarily an easy way to reduce risks when taking nitazenes.
Opioid overdose is life-threatening and often fatal. If you choose to take this substance, know the signs of overdose: slow/shallow/no breathing, blue lips/fingertips, tiny / unresponsive pupils of the eye. We strongly recommend having naloxone (opioid overdose antidote) on hand – you can obtain a kit from your local Needle Exchange Provider . Multiple doses of naloxone may be required to reverse an overdose, and it may wear off before the effect of the opioid does, leading to recurrence of overdose. It is important to remain with a person who has overdosed after administering Naloxone to ensure they are ok and to provide support if overdose does reoccur. We strongly recommend having multiple naloxone ampoules or doses of Nyxoid (nasal spray) if you intend to take nitazenes, and strongly advise calling 111 for an ambulance in addition to naloxone administration if overdose occurs.
Overdose and death and dramatically more likely in combination with other depressants: alcohol, opioids, benzodiazepines, dissociatives, G/1,4-BD. Especially, novel benzos with long half-lives (e.g. bromazolam) taken in the last few days are significantly more likely to contribute to overdose from nitazenes. Nitazenes should not be taken alone – a trusted friend who knows the dosage a person has taken, route of administration, other drugs consumed, signs of overdose and naloxone administration should be present to provide first aid and seek medical support if needed. You won’t get in trouble for calling an ambulance – they only want to ensure you are safe and breathing.
Contact info@knowyourstuff.nz for questions
NEX Dune_568
Substance presumed to be: Methamphetamine
Date brought in for testing: First week of May, 2024
Substances detected in the sample: Methamphetamine - no filler detected.
This sample was consistent with the presence of methamphetamine - no other drugs or filler were detected.
We see a lot of methamphetamine samples which are consistent with the presence of methamphetamine only, but which produce weak or unexpected effects, which can feel similar to a sample which has been substituted or adulterated. We couldn’t detect any filler or adulterant in this sample, and we suspect this effect is most likely to be due to differences in precursors and synthesis methods, which produce different amounts of L-meth versus D-meth (the psychoactive isomer). We’re working to improve our technology to tell this difference, and will update this result once the laboratory has been able to determine the chemical handedness of this sample.
We wrote an article last year with KnowYourStuffNZ explaining some of these differences – have a read here and feel free to return to the Drug Checking clinic you attended to check on this result for updates.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1795
Substance presumed to be: MDMA
Date brought in for testing: Second week of May, 2024
Substances detected in the sample: Caffeine
Caffeine is a legal stimulant drug, which can cause wakefulness and euphoria, but also carries risk of side effects including anxiety. Some people can be allergic to caffeine, and in some combinations with other drugs, caffeine can increase your risk of side effects including brain toxicity. We recommend taking care and having a plan for if something goes wrong when taking caffeine with other drugs.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1798 - UPDATED
UPDATED RESULT:
Laboratory analysis shows no nitazene-type substances, fentanyl-type substances or benzodiazepines were detected.
Analysis results for this sample showed a substance, which could possibly be pirfenidone. Due to technical limitations, we are unable to conclusively identify this substance. If someone chooses to take this substance, we recommend doing plenty of research, and consulting a medical professional to identify any risks, including interaction with other medications you may be taking.
Please feel welcome to return to the Drug Checking clinic you attended for more harm reduction advice.
INITIAL RESULT:
Substance presumed to be: Unknown
Date brought in for testing: First week of May, 2024
Substances detected in the sample: No opioid or benzo-type drug.
Please note: The final result for this sample is still being reviewed by the laboratory, and is subject to change. If this was your sample, you can return to the Drug Checking clinic you attended, for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_1799 - UPDATED
UPDATED RESULT:
Laboratory analysis shows no nitazene-type substances, fentanyl-type substances or benzodiazepines were detected.
Analysis results for this sample showed a substance, which could possibly be pirfenidone. Due to technical limitations, we are unable to conclusively identify this substance. If someone chooses to take this substance, we recommend doing plenty of research, and consulting a medical professional to identify any risks, including interaction with other medications you may be taking.
Please feel welcome to return to the Drug Checking clinic you attended for more harm reduction advice.
INITIAL RESULT:
Substance presumed to be: Unknown
Date brought in for testing: First week of May, 2024
Substances detected in the sample: No opioid or benzo-type drug.
Please note: The final result for this sample is still being reviewed by the laboratory, and is subject to change. If this was your sample, you can return to the Drug Checking clinic you attended, for additional advice to keep you and your community safer.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_584
Substance presumed to be: Trenbolone enanthate
Date brought in for testing: Third week of May, 2024
Substances detected in the sample: Testosterone enanthate
This sample was consistent with containing testosterone enanthate. It's possible some Tren E might be contained as well, but our equipment did not detect it.
Trenbolone and testosterone are both growth hormones, but have different effects in our bodies. Testosterone is naturally produced and approved for use in humans, and is less potent than trenbolone, which does not naturally occur in humans. Testosterone can cause more fluid retention, although generally may have fewer side-effects than trenbolone. This difference in effects you may expect to feel is important to consider when starting a cycle, and self-monitoring throughout your cycle.
If you choose to take this substance, we recommend making regular appointments to see a trusted clinician. Taking enough testosterone to feel the expected level of noticeable effects as if it were trenbolone, may lead to overloading on testosterone. Excess testosterone can turn into estrogen in the body, and you may want to take estrogen blockers to manage this. Steroids (particularly trenbolone) can increase your blood pressure, cholesterol (which can lead to heart disease or failure), or cause damage to your kidneys, liver, nerves and connective tissue. In all cases, a trusted medical professional can help to monitor your blood pressure and hormone levels. Drug Checking can't determine dosage contained in a vial, but regular check-ups and early detection can help you to change your dosing / steroid to reduce side effects, and make sure you get the gains you want while staying safer.
Besides the specific drug contained, steroid solutions can always become contaminated by bacteria and mold in the air. After a steroid solution has been opened or exposed to air, we strongly recommend using a wheel filter to remove germs. If you're getting illicit / counterfeit steroids, they may already be non-sterile when you get them. Using a wheel filter is always recommended when you're not sure how a vial has been prepared. You can get these, clean needles and syringes, and advice to make your draw-up, preparation and shot safest, from your local needle exchange outlet at https://www.nznep.org.nz/outlets
You can find more information online at https://www.nznep.org.nz/resources
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Chch_1677
NEX Chch_1677
Substance presumed to be: Unknown
Date brought in for testing: Second week of May, 2024
Substances detected in the sample: Updated: MDMA – no other drugs detected.
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
It's possible this substance may contain an uncommon drug (M-ALPHA), which can be a byproduct of MDMA production. We recommend waiting until the result is available before choosing to take this substance. If you choose to take an unidentified drug, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained. You can reduce some of your risk when taking an unknown substance by finely crushing, mixing, then swallowing only a quarter (or less) of a dose / pill, waiting 45-60 minutes to see how it affects your body, and having a trusted friend who can administer naloxone and / or call 111 for an ambulance immediately if anyone experiences concerning effects.
UPDATED RESULT: Laboratory analysis has confirmed this sample was consistent with containing MDMA, no other psychoactive drugs were detected.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1685
Substance presumed to be: Unknown
Date brought in for testing: Second week of May, 2024
Substances detected in the sample: Updated: Dimethylpentylone – no other drugs detected.
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
It's possible this sample contained two risky substances: Dimethylpentylone, and a novel drug (MD-valerophenone). Especially in combination, it is likely this sample could cause highly unexpected or dangerous effects. We recommend waiting until the result is available before choosing to take this substance. If you choose to take an unidentified drug, we recommend taking extra care when trying it, in case a potent or large amount of drug is contained. You can reduce some of your risk when taking an unknown substance by finely crushing, mixing, then swallowing only a quarter (or less) of a dose / pill, waiting 45-60 minutes to see how it affects your body, and having a trusted friend who can administer naloxone and / or call 111 for an ambulance immediately if anyone experiences concerning effects.
UPDATED RESULT: Laboratory analysis has confirmed this sample was consistent with containing dimethylpentylone, with no other psychoactive drugs (including MDMA) detected.
Click here for more information on staying safer if you choose to take synthetic cathinones.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_577 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing buprenorphine - no other psychoactive drugs were detected.
Buprenorphine is a prescription medicine and Class C controlled drug, used to treat opioid use disorder. Buprenorphine is an opioid partial agonist. It produces effects such as euphoria or respiratory depression at low to moderate doses. It may also cause side effects including constipation, headache, increased sweating, tiredness or drowsiness, loss of appetite, nausea and vomiting, abdominal pain, skin rashes, itching or hives. If someone chooses to take this substance, we recommend doing plenty of research, and consulting a medical professional to identify any risks, including interactions with other medications you may be taking.
Click here to read more important information about buprenorphine, its effects and side effects and ways to stay safer.
Please feel welcome to return to the Drug Checking clinic you attended for more harm reduction advice.
INITIAL RESULT:
Substance presumed to be: Unknown
Date brought in for testing: Second week of May, 2024
Substances detected in the sample: Inconclusive - awaiting laboratory result. No fentanyl, benzodiazepine or nitazene detected.
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
This sample was not able to be identified at the clinic it was presented to, however our tests indicated there is likely no fentanyl, benzodiazepine or nitazene type drugs contained. Strip tests aren't able to detect to those drugs 100% of times - it's important to consider those drugs (or new chemical analogues of them) are unlikely, but could still be present in a sample that has been checked, and make a plan for what to do if someone experiences an unexpected depressant overdose.
Just because our equipment didn't identify the drug that may be contained in this sample, does not mean there is no drug contained. If you choose to take an unidentified drug, we recommend taking care when trying it, in case a potent or large amount of drug is contained. You can reduce some of your risk when taking an unknown substance by finely crushing, mixing, then swallowing only a quarter (or less) of a dose / pill, waiting 45-60 minutes to see how it affects your body, and having a trusted friend who can administer naloxone and / or call 111 for an ambulance immediately if anyone experiences concerning effects.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_578 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing buprenorphine - no other psychoactive drugs were detected.
Buprenorphine is a prescription medicine and Class C controlled drug, used to treat opioid use disorder. Buprenorphine is an opioid partial agonist. It produces effects such as euphoria or respiratory depression at low to moderate doses. It may also cause side effects including constipation, headache, increased sweating, tiredness or drowsiness, loss of appetite, nausea and vomiting, abdominal pain, skin rashes, itching or hives. If someone chooses to take this substance, we recommend doing plenty of research, and consulting a medical professional to identify any risks, including interactions with other medications you may be taking.
Click here to read more important information about buprenorphine, its effects and side effects and ways to stay safer.
Please feel welcome to return to the Drug Checking clinic you attended for more harm reduction advice.
INITIAL RESULT:
Substance presumed to be: Unknown
Date brought in for testing: Second week of May, 2024
Substances detected in the sample: Inconclusive - pending laboratory results. No fentanyl, benzodiazepine or nitazene detected.
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
This sample was not able to be identified at the clinic it was presented to, however our tests indicated there is likely no fentanyl, benzodiazepine or nitazene type drugs contained. Strip tests aren't able to detect to those drugs 100% of times - it's important to consider those drugs (or new chemical analogues of them) are unlikely, but could still be present in a sample that has been checked, and make a plan for what to do if someone experiences an unexpected depressant overdose.
Just because our equipment didn't identify the drug that may be contained in this sample, does not mean there is no drug contained. If you choose to take an unidentified drug, we recommend taking care when trying it, in case a potent or large amount of drug is contained. You can reduce some of your risk when taking an unknown substance by finely crushing, mixing, then swallowing only a quarter (or less) of a dose / pill, waiting 45-60 minutes to see how it affects your body, and having a trusted friend who can administer naloxone and / or call 111 for an ambulance immediately if anyone experiences concerning effects.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_579
Substance presumed to be: Methamphetamine
Date brought in for testing: Second week of May, 2024
Substances detected in the sample: Methamphetamine
This sample was consistent with the presence of methamphetamine - no other drugs or filler were detected.
We see a lot of methamphetamine samples which are consistent with the presence of methamphetamine only, but which produce weak or unexpected effects, which can feel similar to a sample which has been substituted or adulterated. We couldn’t detect any filler or adulterant in this sample, and we suspect this effect is most likely to be due to differences in precursors and synthesis methods, which produce different amounts of L-meth versus D-meth (the psychoactive isomer). We’re working to improve our technology to tell this difference, and will update this result if the laboratory is able to determine the chemical handedness of this sample.
We wrote an article last year with KnowYourStuffNZ explaining some of these differences – have a read here and feel free to return to the Drug Checking clinic you attended to check on this result for updates.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Dune_580
Substance presumed to be: Methamphetamine
Date brought in for testing: Second week of May, 2024
Substances detected in the sample: Methamphetamine, dimethyl sulfone (MSM)
This sample was consistent with the presence of methamphetamine, with dimethyl sulfone (MSM) added as a filler material. Dimethyl sulfone (MSM) is a relatively inert and harmless filler substance when taken in quantities up to several grams, and is generally regarded as safe for human consumption. We are unable to determine how much drug versus filler is contained in this sample.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Dune_581
Substance presumed to be: Methamphetamine
Date brought in for testing: Second week of May, 2024
Substances detected in the sample: Methamphetamine
This sample was consistent with the presence of methamphetamine - no other drugs or filler were detected.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Dune_588 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing Benzylpiperazine (BZP) - no other psychoactive drugs were detected.
Harm reduction advice for this substance is provided in the initial result below, however please feel welcome to return to the Drug Checking clinic you attended for more information and advice.
INITIAL RESULT:
Substance presumed to be: Unknown
Date brought in for testing: Third week of May, 2024
Substances detected in the sample: Inconclusive - pending laboratory analysis.
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
We are still waiting to hear back from the laboratory on this sample's contents - however we have seen a similar sample recently which matched this one closely. In that previous sample, laboratory analysis found the similar pill to contain both BZP and caffeine. It is possible this pill contents may be different, and we'll update this result as soon as more information is available.
BZP is a synthetic stimulant drug, producing effects similar to dexamphetamine, and side effects which can include nausea, anxiety, vomiting and heart palpitations. Psychosis, and worsening of existing mental health difficulties can also happen after taking BZP. There is very little information about the toxicity of BZP in humans. In repeated (over the course of a night) and high doses, BZP can cause uncontrolled muscle movements, seizures, and unconsciousness requiring hospital care. We recommend avoiding this substance if you have heart issues, seizure disorder, or a history of psychosis. Mixing BZP with other substances or taking high doses is most likely to produce highly unexpected or unpleasant effects. A typical dose of BZP can range between 50 mg and 100 mg (a tenth of a gram) when taken in known quantities - however it is not possible to measure how much drug was contained in this sample. BZP can take a while to take effect - up to two hours - which is worth considering before choosing to take more.
Caffeine is a legal stimulant drug, which can cause wakefulness and euphoria, but also carries risk of side effects including anxiety. Some people can be allergic to caffeine, and in some combinations with other drugs, caffeine can increase your risk of side effects including brain toxicity. We recommend taking care and having a plan for if something goes wrong when taking caffeine with other drugs.
We are unable to determine how much of each drug may be in this sample. Combining more than one stimulant is more stressful for your body, and creates greater risk of negative side effects and overdose. If someone chooses to take this substance, we recommend starting with a small dose (e.g. 1/4 of a pill dissolved in water), not taking it by yourself (have a trusted friend(s) who can get help if needed), avoid mixing it with additional drugs (including alcohol), and watching for signs of stimulant overamping: Chest pain or severe heart palpitations, overheating, splitting headache, agitation / delirium, seizure and unconsciousness. If someone experiences concerning symptoms after taking this drug, phone 111 immediately to seek medical support.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Chch_1705
UPDATED RESULTS
Substance presumed to be: Ketamine
Date brought in for testing: Third week of May, 2024
Substances detected in the sample: Ketamine- No other drugs detected
This substance was consistent with the presence of ketamine using our tools in-clinic and further laboratory testing. No other drugs or filler were detected. Effects of taking a substance can sometimes vary depending on set (mindset – how we are feeling) and setting (our surrounding environment). This can be especially the case with substances that have psychedelic or dissociative effects. Click here for more information on staying safer when taking ketamine.
UPDATED RESULT: Laboratory analysis confirmed this sample was consistent with containing ketamine - no other psychoactive drugs were detected.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1816 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing 2-Fluoro-2-Oxo-PCE.
2-Fluoro-2-Oxo-PCE (aka CanKet, 2F-NENDCK) is a ketamine analogue synthesised to be similar to the dissociative anaesthetic ketamine. Although structurally similar, ketamine analogues, such as 2-Fluoro-2-Oxo-PCE, can produce unexpected and unpredictable effects. A High Alert notification was recently published about this substance – please read this notification for more important information and ways to stay safer. Please feel welcome to return to the Drug Checking clinic you attended for more harm reduction advice.
INITIAL RESULT:
Substance presumed to be: Ketamine
Date brought in for testing: Third week of May, 2024
Substances detected in the sample: Inconclusive ketamine analogue - pending laboratory analysis.
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
This substance was not consistent with the presence of ketamine. Analogues (that is, chemicals where small parts of the structure have been altered) of ketamine are dissociative drugs as well, but often have different potencies and effects which can be very unexpected or unpleasant. The equivalent dose for a ketamine analogue will be different from the amount of ketamine you might normally take. The exact analogue of ketamine present in this sample hasn't been confirmed yet, however novel ketamine analogues are increasingly common and associated with harm in Australia and overseas. Generally speaking, people often find ketamine analogues to more intoxicating / stronger, but with effects which plateau earlier (meaning taking more doesn't give you more good effects). Visual disturbances, confusion, and hangover effects the next day can be more pronounced after taking analogues of ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_1832 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing a mixture ketamine and 2-Fluoro-2-Oxo-PCE.
2-Fluoro-2-Oxo-PCE (aka CanKet, 2F-NENDCK) is a ketamine analogue synthesised to be similar to the dissociative anaesthetic ketamine. Although structurally similar, ketamine analogues, such as 2-Fluoro-2-Oxo-PCE, can produce unexpected and unpredictable effects. A High Alert notification was recently published about this substance – please read this notification for more important information and ways to stay safer. Please feel welcome to return to the Drug Checking clinic you attended for more harm reduction advice.
INITIAL RESULT:
Substance presumed to be: Ketamine
Date brought in for testing: Third week of May, 2024
Substances detected in the sample: Inconclusive ketamine analogue - pending laboratory analysis.
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
This substance was not consistent with the presence of ketamine. Analogues (that is, chemicals where small parts of the structure have been altered) of ketamine are dissociative drugs as well, but often have different potencies and effects which can be very unexpected or unpleasant. The equivalent dose for a ketamine analogue will be different from the amount of ketamine you might normally take. The exact analogue of ketamine present in this sample hasn't been confirmed yet, however novel ketamine analogues are increasingly common and associated with harm in Australia and overseas. Generally speaking, people often find ketamine analogues to more intoxicating / stronger, but with effects which plateau earlier (meaning taking more doesn't give you more good effects). Visual disturbances, confusion, and hangover effects the next day can be more pronounced after taking analogues of ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Wgtn_1862
Substance presumed to be: Amphetamine
Date brought in for testing: Last week of May, 2024
Substances detected in the sample: Caffeine.
This sample was consistent with the presence of caffeine - no other drugs or filler were detected.
Caffeine is a legal stimulant drug, which can cause wakefulness and euphoria, but also carries risk of side effects including anxiety. Some people can be allergic to caffeine, and in some combinations with other drugs, caffeine can increase your risk of side effects including brain toxicity. We recommend taking care and having a plan for if something goes wrong when taking caffeine with other drugs.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1867
Substance presumed to be: Methamphetamine
Date brought in for testing: Last week of May, 2024
Substances detected in the sample: Methamphetamine.
This sample was consistent with the presence of methamphetamine - no other drugs or filler were detected.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1869
Substance presumed to be: Methamphetamine
Date brought in for testing: Last week of May, 2024
Substances detected in the sample: Methamphetamine.
This sample was consistent with the presence of methamphetamine - no other drugs or filler were detected.
Click here for more information on staying safer when taking methamphetamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1873 - UPDATED
UPDATED RESULT:
Laboratory analysis has confirmed this sample was consistent with containing 2-Fluoro-2-Oxo-PCE - no other psychoactive drugs were detected.
2-Fluoro-2-Oxo-PCE (aka CanKet, 2F-NENDCK) is a ketamine analogue synthesised to be similar to the dissociative anaesthetic ketamine. Although structurally similar, ketamine analogues, such as 2-Fluoro-2-Oxo-PCE, can produce unexpected and unpredictable effects. A High Alert notification was recently published about this substance – please read this notification for more important information and ways to stay safer. Please feel welcome to return to the Drug Checking clinic you attended for more harm reduction advice.
INITIAL RESULT:
Substance presumed to be: Ketamine
Date brought in for testing: Third week of May, 2024
Substances detected in the sample: Inconclusive ketamine analogue - pending laboratory analysis.
Please note: This sample is currently at the laboratory for analysis. We'll update this result when results arrive back. If this was your sample, you can return to the Drug Checking clinic you attended to check whether we've heard back, and for additional advice to keep you and your community safer.
This substance was not consistent with the presence of ketamine. Analogues (that is, chemicals where small parts of the structure have been altered) of ketamine are dissociative drugs as well, but often have different potencies and effects which can be very unexpected or unpleasant. The equivalent dose for a ketamine analogue will be different from the amount of ketamine you might normally take. The exact analogue of ketamine present in this sample hasn't been confirmed yet, however novel ketamine analogues are increasingly common and associated with harm in Australia and overseas. Generally speaking, people often find ketamine analogues to more intoxicating / stronger, but with effects which plateau earlier (meaning taking more doesn't give you more good effects). Visual disturbances, confusion, and hangover effects the next day can be more pronounced after taking analogues of ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
24_206_YLN51R
Substance Presumed to be: Sustanon
Date brought in for testing: Third week of May
Substances detected in the sample: Testosterone enanthate (ester of testosterone) + Benzyl benzoate (filler)
If you choose to take this substance, we recommend making regular appointments to see a trusted clinician to confirm you are not overloading on testosterone.
Excess testosterone can turn into estrogen in the body, and you may want to take estrogen blockers to manage this.
Steroids can increase your blood pressure, cholesterol (which can lead to heart disease or failure), or cause damage to your kidneys, liver, nerves and connective tissue. In all cases, a trusted medical professional can help to monitor your blood pressure and hormone levels. Drug Checking can't determine the dosage contained in a vial, but regular check-ups and early detection can help you to change your dosing/steroid to reduce side effects, and make sure you get the results you want while reducing your risks
Steroid solutions can always become contaminated by bacteria and mould in the air. After a steroid solution has been opened or exposed to air, we strongly recommend using a wheel filter to remove germs. If you're getting illicit / counterfeit steroids, they may already be non-sterile when you get them. Using a wheel filter is always recommended when you're not sure how a vial has been prepared. You can get these, clean needles and syringes, and advice to make your draw-up, preparation and shot safest, from our friends over at your local needle exchange outlet at https://www.nznep.org.nz/outlets
Contact info@knowyourstuff.nz for questions
24_206_RBM124
Substance Presumed to be: Nandrolone phenylpropionate
Date Brought in for testing: Third week of May
Substances detected in the sample: Nandrolone decanoate (ester of nandrolone) + Trioctanoin + 2,3-Dioctanoyloxypropyl decanoate + Benzyl benzoate (lipids)
If you choose to take this substance, we recommend making regular appointments to see a trusted clinician to confirm you are not overloading.
Steroids can increase your blood pressure, cholesterol (which can lead to heart disease or failure), or cause damage to your kidneys, liver, nerves and connective tissue. In all cases, a trusted medical professional can help to monitor your blood pressure and hormone levels. Drug Checking can't determine the dosage contained in a vial, but regular check-ups and early detection can help you change your dosing/steroid to reduce side effects and make sure you get the results you want while reducing your risks
Steroid solutions can always become contaminated by bacteria and mould in the air. After a steroid solution has been opened or exposed to air, we strongly recommend using a wheel filter to remove germs. If you're getting illicit/counterfeit steroids, they may already be non-sterile when you get them. A wheel filter is always recommended when you're unsure how a vial has been prepared. You can get these, clean needles and syringes, and advice to make your draw-up, preparation and shot safest, from our friends over at your local needle exchange outlet at https://www.nznep.org.nz/outlets
Contact info@knowyourstuff.nz for questions
April 2024
NEX Wgtn_1643
Substance presumed to be: Diazepam
Date brought in for testing: First week of April, 2024
Substances detected in the sample: (Preliminary result) N-Desethyletonitazene
Please note: The final result for this sample is still being reviewed by the laboratory, and is subject to change. If this was your sample, you can return to the Drug Checking clinic you attended, for additional advice to keep you and your community safer.
We did not detect any benzodiazepine in this sample. The only substance identified was desethyletonitazene, a very potent novel opioid drug. Desethyletonitazene may be up to 10 times as potent as fentanyl. Fentanyl test strips will not detect the presence of a nitazene.
Different nitazenes can have dramatically different potencies, including when injected versus taking orally (can be exponentially more potent taken intravenously). Nitazenes are associated with high degrees of harm in NZ, including hospitalisation and death. Both opioid-naïve and opioid-experienced clients are highly at risk of overdose or death from nitazenes. Volumetric dosing can be particularly challenging with nitazenes due to differences in solubility compared with other opioids, and is not necessarily an easy way to reduce risks when taking nitazenes.
Opioid overdose is life-threatening and often fatal. If you choose to take this substance, know the signs of overdose: slow/shallow/no breathing, blue lips/fingertips, tiny / unresponsive pupils of the eye. We strongly recommend having naloxone (opioid overdose antidote) on hand – you can obtain a kit from your local Needle Exchange Provider (https://www.nznep.org.nz/outlets). Multiple doses of naloxone may be required to reverse an overdose, and it may wear off before the effect of the opioid dose, leading to recurrence of overdose. It is important to remain with a person who has overdosed after administering Naloxone to ensure they are ok and to provide support if overdose does reoccur. We strongly recommend having multiple naloxone ampoules or doses of Nyxoid (nasal spray) if you intend to take nitazenes, and strongly advise calling 111 for an ambulance in addition to naloxone administration if overdose occurs.
Overdose and death and dramatically more likely in combination with other depressants: alcohol, opioids, benzodiazepines, dissociatives, G/1,4-BD. Especially, novel benzos with long half-lives (e.g. bromazolam) taken in the last few days are significantly more likely to contribute to overdose from nitazenes. Nitazenes should not be taken alone – a trusted friend who knows the dosage a person has taken, route of administration, other drugs consumed, signs of overdose and naloxone administration should be present to provide first aid and seek medical support if needed. You won’t get in trouble for calling an ambulance – they only want to ensure you are safe and breathing.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1657
Substance presumed to be: MDMA
Date brought in for testing: First week of April, 2024
Substances detected in the sample: MDMA
This sample was consistent with the presence of MDMA. We are unable to determine the amount of MDMA contained, however it is common for illicit pressed pills to contain multiple "doses" of MDMA in Aotearoa. A single dose of MDMA is typically approximately 80-120 mg (depending on your body), and it's not easy to tell how many doses have been put into one pill. You can sometimes tell by the scored marking on the back, the dose a pill is advertised as containing, or a Drug Checking clinic may be able to see signs that indicate multiple doses may be present.
When MDMA pills contain multiple doses, it can be challenging to know how much to take, has been taken, or to predict the effects that a pill may cause. High doses of MDMA greatly increase the risk of side effects, and risk of interactions with other drugs or medications you may be taking.
The best way to stay safer when taking pills containing unknown amounts of MDMA is to crush a pill up finely, mix it well to ensure the drug contained is evenly distributed, and to divide the powder into sections (e.g. four or eight equal parts), then consume one of those parts and wait 30-45 minutes to see how it affects your body. If you experience any concerning side effects after taking this substance - especially uncontrolled temperature/shivering, agitation/paranoia, an abnormally fast heartbeat, or splitting headache - phone 111 immediately and seek medical support.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1702
Substance presumed to be: Cocaine
Date brought in for testing: Third week of April, 2024
Substances detected in the sample: Cocaine
Cocaine was detected in this sample – no other drugs or filler were detected.
Click here for information on staying safer when taking cocaine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Chch_1537
Substance presumed to be: MDMA
Date brought in for testing: First week of April, 2024
Substances detected in the sample: Traces of ketamine, paracetamol, dimethyl sulfone (MSM)
We did not detect any MDMA in this sample. The psychoactive drug that was found in this sample – ketamine – was present only in traces that could be detected by the laboratory analysis. We are unable to determine how much ketamine may be present in this sample.
We also detected paracetamol (a non-steroidal anti-inflammatory drug, commonly sold as Panadol) and a common filler dimethyl sulfone (abbreviation: MSM). Dimethyl sulfone is a relatively inert and harmless filler substance when taken in quantities up to several grams, and is generally regarded as safe for human consumption. Paracetamol can be harmful when taken in large quantities, and can cause liver damage and death if taken beyond the maximum recommended dosage (for adults: no more than 4 grams in 24 hours).
If you choose to take this substance, we recommend avoiding combining it with alcohol, as it makes liver damage much more likely to occur. If you realise you’ve taken too much, or you experience a severe allergic reaction, unexpected abdominal pain, nausea, vomiting, diarrhoea, yellow skin/eyes or extreme confusion or sleepiness, call 111 immediately and seek medical support.
Click here for information on staying safer when taking ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Chch_1602
Substance presumed to be: Novel benzodiazepine
Date brought in for testing: Third week of April, 2024
Substances detected in the sample: Benzodiazepine (unspecified)
This sample was unable to be conclusively identified at the drug checking clinic it was brought to, but did produce a positive reaction on a Benzodiazepine Test Strip – indicating the presence of a benzodiazepine drug. Different benzos (and especially novel ones, such as those with “flu” at the beginning of the name) can have very different effective dosages, and effects when taken. We recommend returning to the clinic you attended to submit a sample for further checking – this is a totally anonymous way to send a sample to a laboratory for a more specific identification of the drug contained.
Broadly speaking, novel benzodiazepines often produce similar effects as better-known benzos, but can cause unexpectedly large side effects - particularly sedation (drowsiness) and amnesia (memory loss). Some of these novel benzos have a long "elimination half-life" or time until the drug clears your body. This means that even when you no longer feel affected by the drug, there may still be enough in your blood to make the effects of other drugs unexpectedly or unpredictably strong, which can cause someone to overdose. Even the next day after taking this drug, it is much easier to overdose from taking other substances: especially opioids, alcohol, ketamine, G/1,4-BD/Waz or additional benzo.
In liquid form, it can be challenging to know how much of the drug you may have taken. Often the person selling it may have purchased or sold it as a different benzo, or may have mixed a different amount of drug / doses in than would be ideal. If someone chooses to take this substance, we recommend starting with a small amount first (e.g. a quarter of the amount of liquid the vendor has indicated as containing “one dose” for the presumed drug) and waiting an hour to see how it affects you, and having a trusted person nearby who can seek medical help if needed. If someone experiences concerning symptoms (especially slowed breathing / unconsciousness) after taking this drug, call 111 immediately and seek medical support.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Dune_518
Substance presumed to be: MDMA
Date brought in for testing: First week of April, 2024
Substances detected in the sample: MDMA, dimethylsulfone (MSM)
Two of our reagent tests indicated the presence of MDMA, however this was likely to be very low in amount - our machines and the laboratory were unable to detect it. We cannot determine just how much MDMA was contained, and it's possible the rest of this sample may contain more MDMA than the portion that was measured. It's always a good idea to finely crush and mix substances before taking them to ensure whatever amount of drug contained is mixed evenly before dosing.
Dimethyl sulfone is a relatively inert and harmless filler substance when taken in quantities up to several grams, and is generally regarded as safe for human consumption.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1717
Substance presumed to be: Unknown
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Results inconclusive - awaiting laboratory result
Please note: This substance was unable to be conclusively identified at the clinic - we will update this result once the laboratory has had a look. Laboratory confirmation may take up to 2-4 weeks. You can check in with the Drug Checking clinic you attended to find out when more information is available.
From our measurements so far: Based on the filler and format, it is most likely this tablet is of pharmaceutical origin. We are not yet able to exclude the presence of a psychoactive drug in this sample, however we did not detect fentanyl, benzodiazepine or nitazene drugs. Benzodiazepine and nitazene test strips are never 100% - we recommend caution around any unidentified tablet, and avoiding taking a substance until you're confident in its contents.
If someone chooses to take an unidentified tablet: We strongly recommend not taking it by yourself - it's worth having a trusted friend who can call for medical help if needed. Especially for a substance of unknown identity and amount, we would strongly recommend crushing and mixing a tablet to ensure any drug contained is evenly distributed, and taking a small amount (e.g. less than a quarter) and seeing how it affects your body before taking more. If somebody experiences any concerning symptoms after taking an unidentified substance - especially slow/no breathing, blue lips / fingertips, or pinpoint / unresponsive pupils - call 111 and seek medical care immediately.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1720
Substance presumed to be: Cocaine
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Cocaine - no filler detected.
This sample was consistent with the presence of cocaine - no other drugs or filler were detected.
Click here for more information on staying safer when taking cocaine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1721
Substance presumed to be: Cocaine
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Cocaine - no filler detected.
This sample was consistent with the presence of cocaine - no other drugs or filler were detected.
Click here for more information on staying safer when taking cocaine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1722
Substance presumed to be: Ketamine
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Ketamine - no filler detected.
This sample was consistent with the presence of ketamine - no other drugs or filler were detected.
Click here for more information on staying safer when taking ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1734
Substance presumed to be: Cocaine
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Cocaine - no filler detected.
This sample was consistent with the presence of cocaine - no other drugs or filler were detected.
Click here for more information on staying safer when taking cocaine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1735
Substance presumed to be: Unknown
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: MDMA – no filler detected.
This sample was consistent with the presence of MDMA - no other drugs or filler were detected. MDMA can fail to produce expected effects for many reasons – including other medications you may be taking (antidepressants and other drugs like quetiapine), if MDMA or other stimulants have been taken recently, of if your body hasn’t slept or eaten. It’s recommended to leave at least a month (ideally several) between occasions of taking MDMA to maximise the effect you experience from a dose.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1736
Substance presumed to be: Cocaine
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Cocaine - no filler detected.
This sample was consistent with the presence of cocaine - no other drugs or filler were detected.
Click here for more information on staying safer when taking cocaine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1737
Substance presumed to be:
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: MDMA - no filler detected.
This sample was consistent with the presence of MDMA - no other drugs or filler were detected.
Click here for more information on staying safer when taking MDMA.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1717
Substance presumed to be: Unknown
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: (Preliminary result) Zopiclone
Please note: The final result for this sample is still being reviewed by the laboratory, and is subject to change. If this was your sample, you can return to the Drug Checking clinic you attended, for additional advice to keep you and your community safer.
This sample was consistent with the presence of Zopiclone - no other drugs or filler were detected. We are unable to determine the amount of drug contained in the sample or its purity.
Zopiclone is a pharmaceutical drug which can produce some similar effects as benzodiazepine drugs: particularly drowsiness, and helping you to stay asleep. Zopiclone is not a benzodiazepine drug, and so will not show a positive reaction on a benzo test strip - however the effects and risks can be similar. In high doses, or taken regularly or not around sleeping, zopiclone can make it difficult to form and recall memories (amnesia), as well as affecting good decision-making. Overdose on zopiclone can look like difficulty / uncoordinated moving, low blood pressure, or someone may stop breathing and die. Overdose is much more likely if this drug is combined with other depressants: High or repeated doses of this substance, or combination with other benzodiazepine, opioid, dissociative, fantasy-type (G/1,4-BD) drugs or alcohol greatly increases risks of vomiting, stopping breathing, or death.
If someone chooses to take this substance, we recommend starting with a lower dose than may be indicated (e.g. a half or quarter of a tablet), allowing 30-45 minutes for the drug to take effect, and seeing how your body feels before taking more. There is no overdose reversal agent available for first-aid in case of benzo / Z-drug overdose (naloxone will not work for this drug class) - medical care is required to ensure someone stays safe and breathing after an overdose. If you or anybody experiences slow / shallow / no breathing, or blue fingertips or lips after taking this substance, make sure someone phones 111 immediately to seek medical support..
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Chch_1537
Substance presumed to be: MDMA
Date brought in for testing: First week of April, 2024
Substances detected in the sample: Traces of ketamine, dimethyl sulfone (MSM), paracetamol
Please note: The result for this sample is a combination of in-clinic and laboratory checking results. Not all substances were detected by the laboratory, and are presented here as not conclusive, but likely enough to consider building into your risk reduction planning. Both reagents and the spectrometer we use gave good indication of the presence of paracetamol in addition to the drugs the laboratory found (trace ketamine and MSM). Drop back in to the Drug Checking clinic you attended, or get in touch with the team via email or phone for more information and advice around this specific result.
This substance was consistent with the presence of trace amounts of ketamine, and two fillers: dimethylsulfone (MSM) and paracetamol. We are unable to determine the amount of drug contained in the sample or its purity. Dimethyl sulfone (MSM) is a relatively inert and harmless filler substance when taken in quantities up to several grams, and is generally regarded as safe for human consumption. Paracetamol can be harmful when taken in large quantities, and can cause liver damage and death if taken beyond the maximum recommended dosage (for adults: no more than 4 grams in 24 hours).
Click here for more information on staying safer when taking ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Chch_1610
Substance presumed to be: MDMA, ketamine
Date brought in for testing: Third week of April, 2024
Substances detected in the sample: MDMA, starch-like filler.
This sample was consistent with the presence of MDMA - no other drugs were detected.
It's always possible that the bit of sample measured happened to be missing a drug that was present in the rest of the sample. When a sample is advertised as containing multiple drugs, it's wise to assume it could still be present in another part of the sample. Ketamine is a dissociative anaesthetic that worsens your coordination, which you may be less aware of while under the influence of MDMA. Large doses of ketamine and MDMA together may create risk of Serotonin Syndrome, which can be fatal - especially if somebody is taking MAOI type anti-depressants. We are unable to determine how much of each drug may be in this sample.
We can never guarantee the contents of a sample, or that a drug is safe to take. If someone plans to take this substance, we recommend researching dosage, risks associated with the drug/s identified, and the effects you expect to feel. It's always a good idea to have a plan in place to ensure you and others can stay safe if you feel unexpected effects. Avoiding taking drugs alone, making sure your body is well rested, fed and hydrated, and avoiding mixing substances are all great ways to reduce your risk when taking any drug.
Click here for more information on staying safer when taking MDMA and ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Wgtn_1740
Substance presumed to be: Mixed psychoactives
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: (Preliminary result) Ketamine, Nimetazepam, Caffeine, traces of methamphetamine
Please note: The final result for this sample is still being reviewed by the laboratory, and is subject to change. If this was your sample, you can return to the Drug Checking clinic you attended, for additional advice to keep you and your community safer.
This substance was unable to be identified at the Drug Checking clinic - however laboratory analysis indicates 3 (plus a bit) psychoactive drugs may be present. We are unable to determine how much of each drug may be present, and recommend strong caution if you choose to take this substance.
Ketamine is a dissociative anaesthetic commonly used both in medicine and recreation, which can cause effects including hallucinations, worsened coordination, and altered perception of reality. At higher doses, a phenomenon termed the ""K hole"" may be experienced, which can be alarming or hazardous if you aren't highly experienced and expecting it. It's essential to know how much of this drug you may have taken to stay safer when taking it, especially as ketamine's effects can be more strongly pronounced when taken in combination with other substances.
Nimetazepam is a benzodiazepine drug, which can cause effects including sedation, reduction of anxiety, and at higher doses, there is a high risk of amnesia, very strange decision-making, and unconsciousness or death. Taken regularly, benzodiazepines can be highly addictive and dependence-causing. Stopping taking benzodiazepines suddenly can be dangerous once dependence develops - if you're concerned about stopping taking benzos, reach out to a trusted medical professional to find a safe way to stop taking these drugs.
Caffeine is a legal stimulant drug, which can cause wakefulness and euphoria, but also carries risk of side effects including anxiety. In some combinations with other drugs, caffeine can increase your risk of side effects including brain toxicity. We recommend taking care and having a plan for if something goes wrong when taking caffeine with other drugs.
Methamphetamine was also detected, although likely in small amounts. We are unable to determine the amount of any of the drugs contained in the sample, or their purity.
The combination of these substances, and their unknown dosage, may produce dramatically unexpected effects and risk of overdose. In particular, the combination of ketamine and nimetazepam is likely to create risk of unconsciousness or stopping breathing. We strongly recommend avoiding taking this substance in high doses or in combination with other drugs. If you choose to take this substance, start with a very low dose (10 milligrams or less) and wait at least an hour to see how it affects you, and have a trusted friend with you who can get medical help if needed.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz or 0273150929
NEX Dune_546
Substance presumed to be: Ketamine
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Ketamine - no other drugs detected.
Laboratory analysis confirmed this sample was consistent with containing ketamine - no other psychoactive drugs were detected.
Click here for more information on staying safer when taking ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_553
Substance presumed to be: Ketamine
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Ketamine - no other drugs detected.
Laboratory analysis confirmed this sample was consistent with containing ketamine - no other psychoactive drugs were detected.
Click here for more information on staying safer when taking ketamine.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
NEX Dune_541
Substance presumed to be: Cannabis (edible)
Date brought in for testing: Last week of April, 2024
Substances detected in the sample: Tetrahydrocannabinol (THC) - no other drugs detected.
Laboratory analysis confirmed this sample was consistent with containing THC, a major psychoactive component of cannabis products. No other psychoactive drugs were detected.
Click here for more information on staying safer when taking cannabis.
Contact: DISC Drug Checking team drugchecking@nznep.org.nz
Share your feedback on the follow up testing process here. We want to provide you with useful information.
Call the New Zealand Drug Foundation if you want to anonymously talk through these results on (04) 801 6303.